syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187	100.0
CHILDHOOD ABSENCE EPILEPSY	1.52074085	57.05234219516074
MYOCLONIC-ASTASTIC EPILEPSY	1.220712254	45.79642431321154
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.193694	44.78280343709463
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	43.22296669687593
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	37.53646219026713
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.51615023372374
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	1.0	37.51615023372374
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.51615023372374
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.05661993667499
LAFORA DISEASE	0.7730060599999999	29.00021147853887
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.910586896276513
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.748578964	28.083800875229276
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.58878041260787
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.676035614	25.362253658171674
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59421851	22.292790892819475
ROLANDIC EPILEPSY	0.5906213	22.157837422037222
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.842307352786534
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5348101000000001	20.06401605811282
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.772024109228724
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.518324164	19.445527206393265
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.51073636	19.160862011585213
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.022273225845314
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.504116984	18.91252850711571
PAROXYSMAL HEMICRANIA	0.5	18.75807511686187
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.75807511686187
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.75807511686187
INHALATIONAL ANTHRAX	0.5	18.75807511686187
CREST SYNDROME	0.5	18.75807511686187
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.4346148040000001	16.305074280664403
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42074085000000006	15.784576938064628
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.41730050399999996	15.655508400672636
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.340027440062606
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.39053901	14.65152017128974
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3638483	13.650187485084986
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769365
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769365
CENTRALOPATHIC EPILEPSY	0.3547009	13.307012252437023
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.346849954	13.012474982824171
COG4-CDG	0.344567104	12.926831239263114
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.34426350399999994	12.915441336052153
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34259226	12.852742695070946
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841279
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.505370905857834
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.31714300999999995	11.89798480873535
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.302918790252718
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25562995400000005	9.590251758503891
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.254116984	9.533490948684772
PALLISTER-HALL SYNDROME	0.250545554	9.399504644255545
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430936
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430936
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.379037558430936
HYPERPARATHYROIDISM 2	0.25	9.379037558430936
DYSTONIA 6, TORSION	0.25	9.379037558430936
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24304515400000004	9.118118511042525
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.237037	8.892715702951175
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.23608447300000002	8.856980556917497
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.725180206013935
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.475991933577507
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.22536641400000001	8.454880245259583
JUVENILE MYOCLONIC EPILEPSY	0.2214368	8.307456256075037
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.21591692	8.100371608722911
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.21068855000000003	7.904223294325417
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.20704225	7.76742815572819
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.206135503	7.733410499052211
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2051883	7.697875089002378
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	7.50323004674475
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.50323004674475
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.50323004674475
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175000000003	7.105249346027849
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.801145833266899
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.801145833266899
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17747180399999998	6.6580588611139735
UNILATERAL POLYMICROGYRIA	0.17504394999999998	6.566975125704426
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.16415611399999996	6.15850543460828
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.16341620399999998	6.130746859888847
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15970406399999998	5.991481657960231
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.15950570000000003	5.98403980433527
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.15950570000000003	5.98403980433527
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15266181399999998	5.72728354897679
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.6871294881555325
COMBINED SAPOSIN DEFICIENCY	0.1450262	5.440824707026066
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.143402554	5.379911759763681
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14089110999999999	5.285692049356097
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13678895400000002	5.1317949485779275
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968418
NIEMANN-PICK DISEASE, TYPE C2	0.127564073	4.785712927093702
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.127564073	4.785712927093702
LATHOSTEROLOSIS	0.127172739	4.771031581958138
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.1271692	4.770898812302462
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.1271692	4.770898812302462
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.127018519	4.765245841269094
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12107156999999999	4.5421392091528
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12091581399999998	4.536295843656997
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	4.453122163427328
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.432655077602719
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.11601042	4.35226434539739
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.11526449999999999	4.32428029861505
BILATERAL POLYMICROGYRIA	0.106829964	4.007848978887299
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.106758864	4.005181580605681
AICARDI SYNDROME; AIC	0.1036867	3.8899258144390436
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.10170259999999999	3.815490020760312
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.10152670000000001	3.8088909299342006
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.10056305400000001	3.772738641826074
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.7123395157572903
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.098393854	3.69135860873908
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.098393854	3.69135860873908
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185000000001	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185000000001	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185000000001	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185000000001	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185000000001	3.6811540658109063
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.09446700000000001	3.544038164129181
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.093138154	3.494184977955698
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.08299461	3.1136382573493107
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08051991	3.020797040365915
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07847085000000001	2.943924197568001
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.9063256618683644
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07746865400000001	2.9063256618683644
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.885858576043755
WILLIAMS SYNDROME	0.07663135000000001	2.8749132392130665
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.07647713	2.869127498524021
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8628236598002488
JUVENILE ABSENCE EPILEPSY	0.07412774999999999	2.780987805487915
NIEMANN-PICK DISEASE TYPE B	0.07412250000000001	2.7807908456991886
GRISCELLI SYNDROME	0.07399267300000001	2.775920236462795
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.07364505400000002	2.7628789098346984
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.07305992000000001	2.7409269347838388
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.0729486	2.73675063693982
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.700193174409169
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.700193174409169
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.07197415400000001	2.700193174409169
TUBEROUS SCLEROSIS COMPLEX	0.0715302	2.683537729448306
PRIMARY BILIARY CHOLANGITIS	0.07142860000000001	2.67972608858456
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.07142860000000001	2.67972608858456
KENNEDY DISEASE	0.07142860000000001	2.67972608858456
STIFF SKIN SYNDROME	0.07142860000000001	2.67972608858456
HYPOALPHALIPOPROTEINEMIA	0.07142860000000001	2.67972608858456
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07142860000000001	2.67972608858456
SCHINZEL-GIEDION SYNDROME	0.07142860000000001	2.67972608858456
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.07142860000000001	2.67972608858456
ADULT-ONSET STILL DISEASE	0.07142860000000001	2.67972608858456
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103487
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.067601994	2.536166563003291
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.067378873	2.5277959220469928
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067212254	2.5215450186111994
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.5213898893299826
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.066952723	2.511808414624891
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.5010779327865906
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.5010779327865906
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.5010779327865906
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.5010779327865906
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.5010779327865906
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.5010779327865906
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	2.5010779327865906
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.066599404	2.498553245940462
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0662919	2.487016879678991
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.06565660000000001	2.463182869435507
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4316017741687577
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.3484303449081043
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.062479054	2.3439735763249385
PONTINE TEGMENTAL CAP DYSPLASIA	0.062079673	2.3289903387284436
WHITE-SUTTON SYNDROME; WHSUS	0.061841784000000004	2.3200656592654934
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.061387573	2.3030254111516832
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.060846154	2.282713454608291
GIANT CELL ARTERITIS	0.0603006	2.262246368783682
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.060284073	2.2616263393687692
DYSTONIA-APHONIA SYNDROME	0.059910473	2.24761030564145
LYSINURIC PROTEIN INTOLERANCE	0.059889200000000004	2.2468122245775284
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.059369054	2.2272983490980574
ADNP SYNDROME	0.059364919	2.2271432198168415
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.059127030000000004	2.218218540353891
GITELMAN SYNDROME	0.059127030000000004	2.218218540353891
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.0588235	2.2068312632734486
OROMANDIBULAR DYSTONIA	0.0588235	2.2068312632734486
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.0588235	2.2068312632734486
CLEFT LIP AND ALVEOLUS	0.0588235	2.2068312632734486
MYASTHENIA GRAVIS; MG	0.0588235	2.2068312632734486
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.0588235	2.2068312632734486
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0588235	2.2068312632734486
CITRULLINEMIA TYPE II	0.058806973	2.206211233858536
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.058323464	2.1880718375751784
ALSTROM SYNDROME; ALMS	0.058265554	2.1858992773151433
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.1676047517505697
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.05772	2.165432191490534
FISH-EYE DISEASE	0.05772	2.165432191490534
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.05772	2.165432191490534
NIEMANN-PICK DISEASE, TYPE B	0.05772	2.165432191490534
DYSBETALIPOPROTEINEMIA	0.05772	2.165432191490534
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	0.05772	2.165432191490534
ATHEROSCLEROSIS SUSCEPTIBILITY	0.05772	2.165432191490534
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.05772	2.165432191490534
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.084232235924663
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.084232235924663
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.084232235924663
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.084232235924663
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.084232235924663
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.084232235924663
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.084232235924663
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.05161315	1.9363266894357185
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.05161315	1.9363266894357185
CHROMOSOME 17Q12 DELETION SYNDROME	0.05138561999999999	1.927790639773039
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
ALG13-CDG	0.049802	1.8683793139399096
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.8411746276625256
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.049064204	1.8407000483620695
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.048559609999999996	1.8217696240510335
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.04853174399999999	1.8207241990086203
FISH-EYE DISEASE	0.047619	1.786481557979691
HYPOALPHALIPOPROTEINEMIA, PRIMARY	0.047619	1.786481557979691
TANGIER DISEASE; TGD	0.047619	1.786481557979691
APOLIPOPROTEIN A-I DEFICIENCY	0.047619	1.786481557979691
HYPERLIPOPROTEINEMIA, TYPE V	0.047619	1.786481557979691
MENTAL RETARDATION, X-LINKED 98; MRX98	0.04745448299999999	1.780309513491689
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.045775053999999996	1.7173038028208167
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6854321824866583
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.044202130000000006	1.6582937497305876
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.04407925	1.6536837651898673
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.043631804	1.6368973138323886
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.043248754	1.6225267524853606
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.604061153275721
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.604061153275721
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.042578484	1.5973808024682026
DISTAL MONOSOMY 12Q	0.04221225399999999	1.5836412627681058
COG2-CDG	0.04221225399999999	1.5836412627681058
19P13.3 MICRODUPLICATION SYNDROME	0.04217420399999999	1.5822137732517128
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.041998773999999996	1.5756323150162104
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.04141455399999999	1.5537146297266644
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.041271154	1.5483348137831485
ACROCEPHALOPOLYDACTYLY	0.04009282	1.504128258413644
SHPRINTZEN OMPHALOCELE SYNDROME	0.04009282	1.504128258413644
SLC35A2-CDG	0.039845903999999994	1.4948649206625335
16P13.11 MICRODELETION SYNDROME	0.039751754	1.4913327751180288
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.474397834837925
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.03930035	1.474397834837925
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938224
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.03923768	1.4720466977027773
TRICHOTHIODYSTROPHY	0.039213873999999996	1.4711535882303133
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.038937034	1.4607676171996093
CHROMOSOME 1P36 DELETION SYNDROME	0.038547822999999995	1.4461659188509912
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4451708779983423
MYOCLONUS AND ATAXIA	0.0385141	1.4449007617166598
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.4429274122143658
BAZEX SYNDROME; BZX	0.0384615	1.4429274122143658
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0384615	1.4429274122143658
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.4429274122143658
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.4429274122143658
CYCLIC NEUTROPENIA	0.0384615	1.4429274122143658
MAL DE MELEDA	0.0384615	1.4429274122143658
LIP, HAMARTOMATOUS	0.0384615	1.4429274122143658
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.4429274122143658
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.4429274122143658
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	1.4429274122143658
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.4429274122143658
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.4429274122143658
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.4429274122143658
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.4429274122143658
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.4429274122143658
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	1.4429274122143658
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4212340735032172
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.037878800000000004	1.421066751473175
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0376773	1.4135072472010795
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.037640679999999996	1.4121334057795205
LISSENCEPHALY 2; LIS2	0.037582554	1.4099527420310352
CANAVAN DISEASE	0.037037	1.3894856562064262
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.037037	1.3894856562064262
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3894856562064262
CHRISTIANSON SYNDROME	0.037037	1.3894856562064262
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3894856562064262
MCLEOD SYNDROME; MCLDS	0.037037	1.3894856562064262
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3894856562064262
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.3894856562064262
ALPERS-HUTTENLOCHER SYNDROME	0.036842704000000004	1.3821964182806148
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.036784003999999995	1.3799942202618949
PEHO SYNDROME	0.036604173999999996	1.3732476909653644
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.036587399	1.372618357545194
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.03629715000000001	1.361729332456006
DOORS SYNDROME	0.036246124	1.3598150333741796
PMM2-CDG	0.036134142999999994	1.3556139373548568
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.03605862	1.3527806051407556
AICARDI SYNDROME	0.03582953	1.3441860302837119
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3380603932735493
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3380603932735493
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.035543054	1.3334385536293556
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457726
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.03477883	1.3047678112331382
3P25.3 MICRODELETION SYNDROME	0.03433533	1.2881293986044817
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.033606343999999996	1.2607806503102004
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.033369719	1.2519033912611455
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.032803653999999995	1.2306668116790926
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978763
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.032487842999999995	1.2188187987576302
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2101997258544839
WEST SYNDROME	0.0322581	1.2101997258544839
EPILEPSY, PYRIDOXINE-DEPENDENT	0.032129244	1.2053655447999672
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1715134468949702
15Q13.3 MICRODELETION SYNDROME	0.030496093000000002	1.144096006529611
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999995	1.1146413266581097
MENINGIOMA	0.0292549	1.0975312234725647
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901084
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901084
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.028323354000000002	1.0625832037869403
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	1.0625832037869403
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	1.0625832037869403
MENKES DISEASE	0.028319219000000003	1.062428074505724
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623315
DIMPLES, FACIAL	0.027777800000000002	1.0421161179623315
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	1.0421161179623315
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.0421161179623315
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.027777800000000002	1.0421161179623315
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.0421161179623315
OROFACIAL CLEFT 3	0.027777800000000002	1.0421161179623315
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.0421161179623315
CLEFT CHIN	0.027777800000000002	1.0421161179623315
GANGLIOCYTOMA	0.027777800000000002	1.0421161179623315
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.0421161179623315
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.027777800000000002	1.0421161179623315
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.0421161179623315
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.0421161179623315
DWARFISM, LEVI TYPE	0.027777800000000002	1.0421161179623315
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623315
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.0421161179623315
NASAL BONES, ABSENCE OF	0.027777800000000002	1.0421161179623315
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.0421161179623315
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	1.0421161179623315
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.0421161179623315
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.0421161179623315
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.0421161179623315
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.0421161179623315
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.0421161179623315
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.0421161179623315
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.0421161179623315
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.0421161179623315
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	1.0421161179623315
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0421161179623315
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.0421161179623315
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.0421161179623315
19P13.13 MICRODELETION SYNDROME	0.027614793	1.0360007228611827
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0344160781914604
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.0342609489102441
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668517
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668517
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668517
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668517
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.027027	1.0139489923668517
HAREL-YOON SYNDROME; HAYOS	0.026159503999999997	0.981403882103697
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.026124354	0.9800851894229818
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.025983473	0.9747998766619045
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02551296	0.9571480402669845
CK SYNDROME	0.025445593	0.9546206897741892
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.025445593	0.9546206897741892
TETRASOMY 5P	0.025445593	0.9546206897741892
8Q24.3 MICRODELETION SYNDROME	0.025445593	0.9546206897741892
GABRIELE-DE VRIES SYNDROME; GADEVS	0.025442054	0.954487920118512
LAMB-SHAFFER SYNDROME	0.024904173999999998	0.9343087332307968
COHEN-GIBSON SYNDROME; COGIS	0.024904173999999998	0.9343087332307968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730213999999997	0.9277824237361381
17Q23.1Q23.2 MICRODELETION SYNDROME	0.024358619999999997	0.9138416474061878
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.024358619999999997	0.9138416474061878
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.023814273	0.893419843574911
CHROMOSOME 5Q12 DELETION SYNDROME	0.023814273	0.893419843574911
INFANTILE LIVER FAILURE SYNDROME 1	0.023814273	0.893419843574911
MEND SYNDROME	0.023814273	0.893419843574911
MEND SYNDROME; MEND	0.023814273	0.893419843574911
KAGAMI-OGATA SYNDROME	0.023814273	0.893419843574911
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.023814273	0.893419843574911
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.023468314	0.8804407937562021
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.023444749999999997	0.8795567631920946
CHROMOSOME 15Q25 DELETION SYNDROME	0.023272854	0.8731078870315184
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.023272854	0.8731078870315184
SWEENEY-COX SYNDROME; SWCOS	0.023272854	0.8731078870315184
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.023272854	0.8731078870315184
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.023268719	0.8729527577503022
2Q24 MICRODELETION SYNDROME	0.023268719	0.8729527577503022
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.023268719	0.8729527577503022
7Q11.23 MICRODUPLICATION SYNDROME	0.023268719	0.8729527577503022
8P INVERTED DUPLICATION/DELETION SYNDROME	0.023268719	0.8729527577503022
EDINBURGH MALFORMATION SYNDROME	0.023268719	0.8729527577503022
SALT-AND-PEPPER SYNDROME	0.022728403999999997	0.8526822190367677
SPONDYLOOCULAR SYNDROME; SOS	0.0227273	0.8526408012069097
SOTOS SYNDROME 2	0.0227273	0.8526408012069097
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.0227273	0.8526408012069097
STICKLER SYNDROME, TYPE II	0.0227273	0.8526408012069097
FRONTOMETAPHYSEAL DYSPLASIA	0.0227273	0.8526408012069097
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0227273	0.8526408012069097
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.0227273	0.8526408012069097
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8446087435064703
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8446087435064703
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.8446087435064703
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8446087435064703
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.022277173	0.8357537690506542
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.022217949999999997	0.8335319500853623
ANGELMAN SYNDROME	0.022202303000000003	0.8329449348826555
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.021873199000000003	0.820598219776136
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.021595299999999998	0.8101725191423343
X-LINKED ADRENOLEUKODYSTROPHY	0.02133178	0.8002862632327434
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.798583930399738
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.021251304	0.7972671135265343
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	0.7889376277870421
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	0.7889376277870421
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	0.7889376277870421
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	0.7889376277870421
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	0.7889376277870421
ERYTHERMALGIA, PRIMARY	0.02081283	0.7808172570689526
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751291
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751291
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.02070575	0.7768000277019254
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0197131	0.7395596211724196
BRAIN-LUNG-THYROID SYNDROME	0.019566554	0.7340617794202683
RIDDLE SYNDROME	0.019566554	0.7340617794202683
FRAXE INTELLECTUAL DISABILITY	0.01917522	0.7193804342847042
MOEBIUS SYNDROME; MBS	0.01917522	0.7193804342847042
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.019117253999999997	0.717205773120256
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.019082104	0.7158870804395407
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.019021	0.7135946935956593
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.019021	0.7135946935956593
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.019021	0.7135946935956593
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.019016264	0.7134170171081524
SPINOCEREBELLAR ATAXIA TYPE 13	0.018630873000000003	0.6989586304534274
ADULT-ONSET DYSTONIA-PARKINSONISM	0.018630873000000003	0.6989586304534274
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.01853655	0.6954199946149318
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.01853655	0.6954199946149318
AMISH INFANTILE EPILEPSY SYNDROME	0.01853655	0.6954199946149318
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
PERMANENT NEONATAL DIABETES MELLITUS	0.018324163999999997	0.687452089531392
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.018089454	0.678646673910035
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.018089454	0.678646673910035
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.018089454	0.678646673910035
INHERITED CREUTZFELDT-JAKOB DISEASE	0.018085319000000002	0.6784915446288186
HUNTINGTON DISEASE-LIKE 1	0.018085319000000002	0.6784915446288186
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.018085319000000002	0.6784915446288186
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.018085319000000002	0.6784915446288186
TENORIO SYNDROME; TNORS	0.018085319000000002	0.6784915446288186
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.018085319000000002	0.6784915446288186
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.018032034	0.6764924965636144
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.017815584	0.668372125845525
GAUCHER DISEASE	0.017778609999999997	0.6669850037067832
DYSTONIA 7, TORSION	0.0175439	0.658179588085426
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.0175439	0.658179588085426
FAMILIAL CONGENITAL MIRROR MOVEMENTS	0.0175439	0.658179588085426
DISTAL MYOPATHY, WELANDER TYPE	0.0175439	0.658179588085426
PANDAS	0.0175439	0.658179588085426
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.0175439	0.658179588085426
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.0175439	0.658179588085426
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.0175439	0.658179588085426
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.0175439	0.658179588085426
DISTAL MYOPATHY, TATEYAMA TYPE	0.0175439	0.658179588085426
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.0175439	0.658179588085426
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.0175439	0.658179588085426
MYOPATHY, DISTAL 3	0.0175439	0.658179588085426
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.0175439	0.658179588085426
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.0175439	0.658179588085426
SPINOCEREBELLAR ATAXIA TYPE 3	0.0175439	0.658179588085426
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.0175439	0.658179588085426
MACHADO-JOSEPH DISEASE TYPE 1	0.0175439	0.658179588085426
WILSON DISEASE	0.0175439	0.658179588085426
TIBIAL MUSCULAR DYSTROPHY	0.0175439	0.658179588085426
EPISODIC ATAXIA TYPE 1	0.0175439	0.658179588085426
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.0175439	0.658179588085426
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0175439	0.658179588085426
MACHADO-JOSEPH DISEASE TYPE 2	0.0175439	0.658179588085426
MACHADO-JOSEPH DISEASE TYPE 3	0.0175439	0.658179588085426
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397246
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397246
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397246
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397246
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397246
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397246
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397246
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397246
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397246
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397246
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397246
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397246
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6468309526397246
TRANSSEXUALITY	0.0172414	0.6468309526397246
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397246
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397246
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397246
PALMOMENTAL REFLEX	0.0172414	0.6468309526397246
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397246
CERVICAL RIB	0.0172414	0.6468309526397246
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397246
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397246
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397246
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397246
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397246
MOSAIC TRISOMY 15	0.0172414	0.6468309526397246
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397246
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6468309526397246
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397246
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397246
THUMBS, CONGENITAL CLASPED	0.0172414	0.6468309526397246
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397246
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6468309526397246
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397246
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397246
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397246
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397246
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6468309526397246
SICKLE CELL ANEMIA	0.0172414	0.6468309526397246
MOTION SICKNESS	0.0172414	0.6468309526397246
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397246
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397246
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397246
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397246
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397246
DIASTEMATOMYELIA	0.0172414	0.6468309526397246
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397246
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397246
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.017102273999999997	0.6416114807223073
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.016948053999999997	0.6358257400332625
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.016847064000000002	0.6320369840211589
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064	0.6320369840211588
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016847064	0.6320369840211588
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.016799254	0.6302433368784846
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.016413353999999998	0.6157658545032905
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.016413353999999998	0.6157658545032905
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.016402499999999997	0.6153586542086537
MYOCLONIC-ATONIC EPILEPSY	0.016402499999999997	0.6153586542086537
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.015867799999999998	0.5952987686786816
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.015841630000000002	0.5943169710270652
PEHO-LIKE SYNDROME; PEHOL	0.015840373999999997	0.5942698507423714
PYRIDOXINE-DEPENDENT EPILEPSY	0.015827734	0.5937956466034172
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.015721253999999997	0.5898009269265302
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.015717118999999998	0.5896457976453138
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.015686153999999997	0.5884841100533265
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5804106345230292
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5804106345230292
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5804106345230292
DESMOSTEROLOSIS	0.015294819999999999	0.5738027649177625
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.015175699999999999	0.5693338411019213
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.015175699999999999	0.5693338411019213
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.015148274	0.5683049231656112
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984203
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984203
SMITH-MAGENIS SYNDROME; SMS	0.014759403	0.5537159803080729
SMITH-MAGENIS SYNDROME	0.014759403	0.5537159803080729
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.014750472999999998	0.5533809610864857
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.014244153999999998	0.534385821416297
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.534385821416297
AYMÃ‰-GRIPP SYNDROME	0.014244153999999998	0.534385821416297
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.534385821416297
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.534385821416297
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.014209053999999999	0.5330690045430932
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.014209053999999999	0.5330690045430932
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.014209053999999999	0.5330690045430932
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.014209053999999999	0.5330690045430932
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.014209053999999999	0.5330690045430932
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.014209053999999999	0.5330690045430932
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.0140845	0.5283962179668821
HYPERPROLINEMIA, TYPE I	0.014058372999999999	0.5274160335097255
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.013869853	0.5203434888676639
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.513918735591688
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.513918735591688
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.513918735591688
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.513918735591688
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.513918735591688
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.513918735591688
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.513918735591688
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.513918735591688
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.513918735591688
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.013671174	0.5128898176553779
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.013671174	0.5128898176553779
RING CHROMOSOME 14 SYNDROME	0.013671174	0.5128898176553779
WRINKLY SKIN SYNDROME	0.013671174	0.5128898176553779
PERLMAN SYNDROME	0.013671174	0.5128898176553779
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.013671174	0.5128898176553779
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.013663499999999999	0.5126019187184843
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.013516954	0.507104076966333
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.013516953999999998	0.507104076966333
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.013516953999999998	0.507104076966333
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.013516953999999998	0.507104076966333
KRABBE DISEASE	0.013451114	0.5046340136349448
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.013406843	0.5029731361479476
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.013328434	0.5000315323242714
INFANTILE DYSTONIA-PARKINSONISM	0.013328434	0.5000315323242714
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.013324299	0.4998764030430551
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.0129714	0.4866369911417241
LYSOSOMAL ACID LIPASE DEFICIENCY	0.012815754	0.48079775242244605
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.012665073	0.4751447813890783
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.012665073	0.4751447813890783
TEMPLE SYNDROME	0.0122702	0.4603306665978371
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.012244999999999999	0.4593852596119472
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.012123654000000001	0.4548328248456858
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.012119519	0.45467769556446935
MELAS	0.01209078	0.4535995189229024
FUMARASE DEFICIENCY; FMRD	0.012039854	0.45168897145609965
BETA-UREIDOPROPIONASE DEFICIENCY	0.012039854	0.45168897145609965
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.45168897145609965
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.45168897145609965
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.011974014	0.4492189081247114
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.011929743	0.44755803063771415
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.011823333	0.4435659370913437
ALG11-CDG	0.011775523	0.44177228994866935
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.011700653	0.4389634557806704
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.011700653	0.4389634557806704
PROPIONIC ACIDEMIA	0.011700653	0.4389634557806704
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.011578100000000001	0.4343657390210769
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.4312218856314908
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.4312218856314908
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4312218856314908
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.4312218856314908
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.011436134	0.4290397212369961
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.01142846	0.42875182230010245
X SMALL RINGS	0.011388324	0.4272460740943217
BIOTINIDASE DEFICIENCY	0.011281914	0.42325398054795116
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.011281914	0.42325398054795116
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.011277779	0.42309885126673474
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.011277779	0.42309885126673474
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.011229969	0.4213052041240604
XP21 MICRODELETION SYNDROME	0.011187973	0.4197296758788449
ALSTRÃ–M SYNDROME	0.011187973	0.4197296758788449
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.011187973	0.4197296758788449
GLYCEROL KINASE DEFICIENCY; GKD	0.011187973	0.4197296758788449
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.011187973	0.4197296758788449
9Q33.3Q34.11 MICRODELETION SYNDROME	0.011155099	0.4184963699560615
XQ12-Q13.3 DUPLICATION SYNDROME	0.01089058	0.40857263541238714
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01083013	0.40630478413075855
MERRF	0.01073636	0.4027868947233422
GAUCHER DISEASE TYPE 3	0.01073636	0.4027868947233422
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.01073636	0.4027868947233422
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.010696224	0.4012811465175616
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.010646554	0.3994177193354525
RECURRENT ACUTE PANCREATITIS	0.010642419	0.399262590054236
EMANUEL SYNDROME	0.010615483	0.39825205503154043
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.010298423	0.3863571844384359
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.010298423	0.3863571844384359
AICARDI-GOUTIERES SYNDROME 7	0.010298423	0.3863571844384359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.010298423	0.3863571844384359
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.010298423	0.3863571844384359
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.010298423	0.3863571844384359
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.010298423	0.3863571844384359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.010298423	0.3863571844384359
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.010298423	0.3863571844384359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.010298423	0.3863571844384359
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.010298423	0.3863571844384359
CIDEC-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.37895063351084357
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.37895063351084357
LYSOSOMAL ACID LIPASE DEFICIENCY	0.010101	0.37895063351084357
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.010101	0.37895063351084357
PROTOPORPHYRIA, ERYTHROPOIETIC	0.010101	0.37895063351084357
LIPE-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.37895063351084357
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.010101	0.37895063351084357
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.010101	0.37895063351084357
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.010101	0.37895063351084357
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.010101	0.37895063351084357
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.010101	0.37895063351084357
GLYCOGEN STORAGE DISEASE VI	0.010101	0.37895063351084357
MANDIBULOACRAL DYSPLASIA	0.010101	0.37895063351084357
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.010101	0.37895063351084357
NEUTRAL LIPID STORAGE MYOPATHY	0.010101	0.37895063351084357
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.010101	0.37895063351084357
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.010101	0.37895063351084357
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.010101	0.37895063351084357
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.010101	0.37895063351084357
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.010101	0.37895063351084357
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.010101	0.37895063351084357
ATYPICAL WERNER SYNDROME	0.010101	0.37895063351084357
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.010101	0.37895063351084357
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.010101	0.37895063351084357
HYPERLIPIDEMIA DUE TO HEPATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.010101	0.37895063351084357
HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH	0.010101	0.37895063351084357
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.010101	0.37895063351084357
LCAT DEFICIENCY	0.010101	0.37895063351084357
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.010101	0.37895063351084357
TANGIER DISEASE	0.010101	0.37895063351084357
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.010101	0.37895063351084357
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.010101	0.37895063351084357
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.010101	0.37895063351084357
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.010101	0.37895063351084357
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.010101	0.37895063351084357
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.010101	0.37895063351084357
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.37895063351084357
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.010101	0.37895063351084357
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.010101	0.37895063351084357
AKT2-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.37895063351084357
HYPERLIPOPROTEINEMIA, TYPE IV	0.010101	0.37895063351084357
GLYCOGEN STORAGE DISEASE IXC	0.010101	0.37895063351084357
ACQUIRED GENERALIZED LIPODYSTROPHY	0.010101	0.37895063351084357
ALAGILLE SYNDROME 1; ALGS1	0.010101	0.37895063351084357
APOLIPOPROTEIN C-II DEFICIENCY	0.010101	0.37895063351084357
H SYNDROME	0.010101	0.37895063351084357
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.010101	0.37895063351084357
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.010101	0.37895063351084357
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.010101	0.37895063351084357
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.010101	0.37895063351084357
CHOLESTERYL ESTER STORAGE DISEASE	0.010101	0.37895063351084357
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.010101	0.37895063351084357
GLYCOGEN STORAGE DISEASE IXA	0.010101	0.37895063351084357
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.010077603000000001	0.3780728681438251
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.009936023	0.37276133159373454
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.009936023	0.37276133159373454
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.36783887503771784
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.36783887503771784
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.36783887503771784
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.36783887503771784
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.36783887503771784
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.009804814	0.36783887503771784
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.36783887503771784
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.009760543	0.3661779975507206
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.009760543	0.3661779975507206
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.009760543	0.3661779975507206
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.009757004	0.3660452278950435
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.009752868999999999	0.365890098613827
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.009752868999999999	0.365890098613827
RETINITIS PIGMENTOSA 59; RP59	0.009752868999999999	0.365890098613827
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.009752868999999999	0.365890098613827
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.009752868999999999	0.365890098613827
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.009606323	0.36039225686167575
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.009606323	0.36039225686167575
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.009377829	0.35182004163017133
PAINE SYNDROME	0.00925926	0.3473717892131089
CARNOSINASE DEFICIENCY	0.00925926	0.3473717892131089
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3473717892131089
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3473717892131089
GLYCINE ENCEPHALOPATHY	0.00925926	0.3473717892131089
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
HYDROXYLYSINURIA	0.00925926	0.3473717892131089
CARNOSINEMIA	0.00925926	0.3473717892131089
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.3473717892131089
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3473717892131089
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3473717892131089
GAUCHER DISEASE TYPE 2	0.00925926	0.3473717892131089
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.3473717892131089
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.3473717892131089
1Q44 MICRODELETION SYNDROME	0.009219124	0.3458660410073282
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.00921145	0.3455781420704346
AMISH LETHAL MICROCEPHALY	0.00921145	0.3455781420704346
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00921145	0.3455781420704346
SARCOSINEMIA	0.009064904	0.3400803003182833
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.009064904	0.3400803003182833
LISSENCEPHALY, X-LINKED, 1; LISX1	0.009060769	0.3399251710370668
CHROMOSOME 13Q14 DELETION SYNDROME	0.00867357	0.3253989551827193
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00851935	0.31961321449367436
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00851935	0.31961321449367436
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00851935	0.31961321449367436
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.008458923	0.3173462260835011
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.008446283	0.3168720219445469
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.008446283	0.3168720219445469
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.008304703	0.3115604853944563
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.008129223	0.30497715135144243
LISSENCEPHALY 1; LIS1	0.008129223	0.30497715135144243
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.008129223	0.30497715135144243
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.008129223	0.30497715135144243
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.008129223	0.30497715135144243
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.008129223	0.30497715135144243
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.008129223	0.30497715135144243
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.008129223	0.30497715135144243
AICARDI-GOUTIÃˆRES SYNDROME	0.008129223	0.30497715135144243
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.008129223	0.30497715135144243
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.008129223	0.30497715135144243
HEART AND BRAIN MALFORMATION SYNDROME	0.008129223	0.30497715135144243
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.008129223	0.30497715135144243
LISSENCEPHALY 8; LIS8	0.008129223	0.30497715135144243
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.008129223	0.30497715135144243
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.008129223	0.30497715135144243
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.008129223	0.30497715135144243
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.008129223	0.30497715135144243
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.008129223	0.30497715135144243
MEHMO SYNDROME; MEHMO	0.008129223	0.30497715135144243
GM2-GANGLIOSIDOSIS, AB VARIANT	0.008129223	0.30497715135144243
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.007913369	0.2968791402588922
48,XXYY SYNDROME	0.007766823000000001	0.29138129850674094
TURNPENNY-FRY SYNDROME; TPFS	0.007587804	0.28466519480804997
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.007587804	0.28466519480804997
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.007587804	0.28466519480804997
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.007587804	0.28466519480804997
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.28466519480804997
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.007587804	0.28466519480804997
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.007587804	0.28466519480804997
HYPERMANGANESEMIA WITH DYSTONIA 2	0.007587804	0.28466519480804997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.007587804	0.28466519480804997
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.007587804	0.28466519480804997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.007587804	0.28466519480804997
W SYNDROME	0.007587804	0.28466519480804997
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.007587804	0.28466519480804997
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.28466519480804997
PELGER-HUET ANOMALY; PHA	0.007587804	0.28466519480804997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.007587804	0.28466519480804997
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.007587804	0.28466519480804997
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.28466519480804997
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.007587804	0.28466519480804997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.28466519480804997
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.007587804	0.28466519480804997
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.007587804	0.28466519480804997
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.007587804	0.28466519480804997
AICARDI-GOUTIERES SYNDROME 5	0.007587804	0.28466519480804997
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.28466519480804997
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007587804	0.28466519480804997
DEND SYNDROME	0.0075836689999999995	0.2845100655268335
WARBURG MICRO SYNDROME 3; WARBM3	0.0075836689999999995	0.2845100655268335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.0075836689999999995	0.2845100655268335
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.0075836689999999995	0.2845100655268335
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2845100655268335
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.0075836689999999995	0.2845100655268335
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.0075836689999999995	0.2845100655268335
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2845100655268335
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.0075836689999999995	0.2845100655268335
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.0075836689999999995	0.2845100655268335
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.0075836689999999995	0.2845100655268335
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.0075836689999999995	0.2845100655268335
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00735931	0.2760929795765455
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00704225	0.26419810898344104
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.26419810898344104
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.26419810898344104
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.26419810898344104
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26419810898344104
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.26419810898344104
WARBURG MICRO SYNDROME 2; WARBM2	0.00704225	0.26419810898344104
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00704225	0.26419810898344104
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.00704225	0.26419810898344104
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.00704225	0.26419810898344104
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26419810898344104
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26419810898344104
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.00704225	0.26419810898344104
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00704225	0.26419810898344104
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00704225	0.26419810898344104
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.00704225	0.26419810898344104
OLIVER SYNDROME	0.00704225	0.26419810898344104
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26419810898344104
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26419810898344104
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.26419810898344104
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26419810898344104
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.26419810898344104
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.26419810898344104
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.26419810898344104
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26419810898344104
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26419810898344104
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.26419810898344104
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26419810898344104
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26419810898344104
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.26419810898344104
HALLERMANN-STREIFF SYNDROME; HSS	0.00704225	0.26419810898344104
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26419810898344104
SCHAAF-YANG SYNDROME; SHFYNG	0.006827603	0.2561453798842229
EMANUEL SYNDROME	0.006827603	0.2561453798842229
PITT-HOPKINS SYNDROME	0.006827603	0.2561453798842229
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.006827603	0.2561453798842229
PRADER-WILLI-LIKE SYNDROME	0.006827603	0.2561453798842229
CHROMOSOME 19P13.13 DELETION SYNDROME	0.006827603	0.2561453798842229
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.006827603	0.2561453798842229
DESANTO-SHINAWI SYNDROME	0.006827603	0.2561453798842229
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.006827603	0.2561453798842229
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.006827603	0.2561453798842229
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.006827603	0.2561453798842229
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.006827603	0.2561453798842229
NEPHROGENIC DIABETES INSIPIDUS	0.006827603	0.2561453798842229
CHROMOSOME 10Q26 DELETION SYNDROME	0.0065061730000000005	0.24408656371459714
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.0065061730000000005	0.24408656371459714
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0065061730000000005	0.24408656371459714
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.006364593	0.2387750271645065
DISTAL MONOSOMY 10Q	0.006364593	0.2387750271645065
SALLA DISEASE	0.0063519530000000005	0.23830082302555225
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0063519530000000005	0.23830082302555225
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0063519530000000005	0.23830082302555225
48,XXXY SYNDROME	0.0062897230000000005	0.23596619299650762
HOLOPROSENCEPHALY	0.0062897230000000005	0.23596619299650762
WIEDEMANN-STEINER SYNDROME; WDSTS	0.0062897230000000005	0.23596619299650762
1P36 DELETION SYNDROME	0.0062897230000000005	0.23596619299650762
JACOBSEN SYNDROME	0.0062897230000000005	0.23596619299650762
RUBINSTEIN-TAYBI SYNDROME	0.0062897230000000005	0.23596619299650762
22Q11.2 DELETION SYNDROME	0.0062897230000000005	0.23596619299650762
49,XXXXY SYNDROME	0.0062897230000000005	0.23596619299650762
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0062897230000000005	0.23596619299650762
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.0062897230000000005	0.23596619299650762
COFFIN-SIRIS SYNDROME 7; CSS7	0.006286184	0.23583342334083046
PERMANENT CONGENITAL HYPOTHYROIDISM	0.006286184	0.23583342334083046
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.006286184	0.23583342334083046
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.006286184	0.23583342334083046
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.006286184	0.23583342334083046
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.006286184	0.23583342334083046
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.006286184	0.23583342334083046
AU-KLINE SYNDROME; AUKS	0.006286184	0.23583342334083046
PERIPHERAL HYPOTHYROIDISM	0.006286184	0.23583342334083046
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.006286184	0.23583342334083046
ATHYREOSIS	0.006286184	0.23583342334083046
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.006282049	0.235678294059614
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.006282049	0.235678294059614
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.006282049	0.235678294059614
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.006282049	0.235678294059614
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.0061355030000000005	0.23018045230746276
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.0061355030000000005	0.23018045230746276
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.0061355030000000005	0.23018045230746276
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.0061355030000000005	0.23018045230746276
CUTIS LAXA	0.005964754	0.22377460717120465
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00595708	0.22348670823431105
BAKER-GORDON SYNDROME; BAGOS	0.0058231739999999995	0.21846307062111403
REVESZ SYNDROME	0.005810534	0.21798886648215976
NEURONAL CEROID LIPOFUSCINOSIS	0.005806399	0.21783373720094332
COFFIN-SIRIS SYNDROME 6; CSS6	0.005748304	0.21565423645311513
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.005748304	0.21565423645311513
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.005744169	0.21549910717189869
MOWAT-WILSON SYNDROME	0.005744169	0.21549910717189869
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.005744169	0.21549910717189869
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.005744169	0.21549910717189869
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.005744169	0.21549910717189869
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.005744169	0.21549910717189869
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.005744169	0.21549910717189869
TEMPLE-BARAITSER SYNDROME	0.005744169	0.21549910717189869
C SYNDROME	0.005744169	0.21549910717189869
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00574063	0.21536633751622153
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.00574063	0.21536633751622153
SILVER-RUSSELL SYNDROME	0.00574063	0.21536633751622153
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00574063	0.21536633751622153
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00574063	0.21536633751622153
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00574063	0.21536633751622153
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00574063	0.21536633751622153
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00574063	0.21536633751622153
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.005594084	0.20986849576407024
WOLFRAM SYNDROME	0.005589949	0.20971336648285382
GITELMAN SYNDROME	0.005589949	0.20971336648285382
ALEXANDER DISEASE	0.005589949	0.20971336648285382
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.005589949	0.20971336648285382
2Q23.1 MICRODELETION SYNDROME	0.005589949	0.20971336648285382
EHLERS-DANLOS SYNDROME, TYPE VI	0.0054192	0.20330752134659572
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.005277619999999999	0.1979959847965051
REFSUM DISEASE	0.00526498	0.19752178065755083
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00526498	0.19752178065755083
CEREBELLOPARENCHYMAL DISORDER V	0.00526498	0.19752178065755083
46,XX GONADAL DYSGENESIS	0.00526498	0.19752178065755083
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00526498	0.19752178065755083
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00526498	0.19752178065755083
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00520275	0.1951871506285062
WILLIAMS-BEUREN SYNDROME; WBS	0.00520275	0.1951871506285062
TYPHOID	0.00504853	0.18940140993946133
NEUROFERRITINOPATHY	0.00504853	0.18940140993946133
TURCOT SYNDROME WITH POLYPOSIS	0.00504853	0.18940140993946133
TETRASOMY 9P	0.004887493	0.18335992165427314
MONOSOMY 9Q22.3	0.004887493	0.18335992165427314
MONOSOMY 22Q13.3	0.004887493	0.18335992165427314
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.004887493	0.18335992165427314
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.004887493	0.18335992165427314
PHELAN-MCDERMID SYNDROME	0.004887493	0.18335992165427314
8P11.2 DELETION SYNDROME	0.004887493	0.18335992165427314
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.004887493	0.18335992165427314
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.004887493	0.18335992165427314
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.004887493	0.18335992165427314
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.004887493	0.18335992165427314
11Q22.2Q22.3 MICRODELETION SYNDROME	0.004887493	0.18335992165427314
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.004887493	0.18335992165427314
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.004887493	0.18335992165427314
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004887493	0.18335992165427314
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.004887493	0.18335992165427314
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.004887493	0.18335992165427314
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.004887493	0.18335992165427314
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004874853	0.1828857175153189
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004874853	0.1828857175153189
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.004874853	0.1828857175153189
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.004874853	0.1828857175153189
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.004733273	0.17757418096522826
RFT1-CDG	0.004733273	0.17757418096522826
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.004733273	0.17757418096522826
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.004733273	0.17757418096522826
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.004733273	0.17757418096522826
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.004733273	0.17757418096522826
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.004733273	0.17757418096522826
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.004733273	0.17757418096522826
JOUBERT SYNDROME WITH RENAL DEFECT	0.004733273	0.17757418096522826
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.004733273	0.17757418096522826
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.004733273	0.17757418096522826
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.004733273	0.17757418096522826
JOUBERT SYNDROME WITH OCULAR DEFECT	0.004733273	0.17757418096522826
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.004733273	0.17757418096522826
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.004733273	0.17757418096522826
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.004658403	0.1747653467972294
KAGAMI-OGATA SYNDROME	0.004658403	0.1747653467972294
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.004658403	0.1747653467972294
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.004658403	0.1747653467972294
XQ28 (MECP2) DUPLICATION	0.004658403	0.1747653467972294
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.004658403	0.1747653467972294
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.004658403	0.1747653467972294
KLEEFSTRA SYNDROME	0.004658403	0.1747653467972294
611961 STEVENSON-CAREY SYNDROME	0.004658403	0.1747653467972294
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.004658403	0.1747653467972294
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.004658403	0.1747653467972294
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.004658403	0.1747653467972294
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.004658403	0.1747653467972294
HOLOPROSENCEPHALY 2; HPE2	0.004658403	0.1747653467972294
FG SYNDROME TYPE 1	0.004658403	0.1747653467972294
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.004658403	0.1747653467972294
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.004346073999999999	0.16304796511088065
2P15P16.1 MICRODELETION SYNDROME	0.004346073999999999	0.16304796511088065
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.004346073999999999	0.16304796511088065
16P11.2P12.2 MICRODELETION SYNDROME	0.004346073999999999	0.16304796511088065
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.004346073999999999	0.16304796511088065
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.004346073999999999	0.16304796511088065
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.004346073999999999	0.16304796511088065
HOLMES-GANG SYNDROME	0.004346073999999999	0.16304796511088065
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004346073999999999	0.16304796511088065
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.004346073999999999	0.16304796511088065
48,XYYY SYNDROME	0.004346073999999999	0.16304796511088065
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.004346073999999999	0.16304796511088065
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.004346073999999999	0.16304796511088065
CHROMOSOME 17P13.1 DELETION SYNDROME	0.004346073999999999	0.16304796511088065
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.004346073999999999	0.16304796511088065
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.004346073999999999	0.16304796511088065
PALLISTER-KILLIAN SYNDROME	0.0043419389999999995	0.1628928358296642
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0043419389999999995	0.1628928358296642
14Q12 MICRODELETION SYNDROME	0.0043419389999999995	0.1628928358296642
DUPLICATION/INVERSION 15Q11	0.0043419389999999995	0.1628928358296642
WIEDEMANN-STEINER SYNDROME	0.0043419389999999995	0.1628928358296642
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0043419389999999995	0.1628928358296642
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.0043419389999999995	0.1628928358296642
LARSEN-LIKE SYNDROME	0.004333434	0.16257376097192638
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004333434	0.16257376097192638
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.004333434	0.16257376097192638
EPILEPSY-TELANGIECTASIA	0.004329299	0.16241863169070997
XYLOSIDASE DEFICIENCY	0.004329299	0.16241863169070997
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004329299	0.16241863169070997
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004329299	0.16241863169070997
HYPERLEUCINE-ISOLEUCINEMIA	0.004329299	0.16241863169070997
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004329299	0.16241863169070997
GAPO SYNDROME; GAPOS	0.004329299	0.16241863169070997
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.004329299	0.16241863169070997
ICHTHYOSIS AND MALE HYPOGONADISM	0.004329299	0.16241863169070997
ASPARTYLGLUCOSAMINURIA; AGU	0.004329299	0.16241863169070997
NEONATAL ADRENOLEUKODYSTROPHY	0.004329299	0.16241863169070997
15Q11Q13 MICRODUPLICATION SYNDROME	0.004195393	0.15739499407751298
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.0041953929999999995	0.15739499407751292
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.0041953929999999995	0.15739499407751292
PYRUVATE DEHYDROGENASE DEFICIENCY	0.0041953929999999995	0.15739499407751292
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.0041953929999999995	0.15739499407751292
WOLF-HIRSCHHORN SYNDROME	0.0041953929999999995	0.15739499407751292
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.0041953929999999995	0.15739499407751292
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.0041953929999999995	0.15739499407751292
OROFACIODIGITAL SYNDROME TYPE 6	0.0041953929999999995	0.15739499407751292
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.004191854	0.1572622244218358
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.004191854	0.1572622244218358
ISOLATED COMPLEX I DEFICIENCY	0.004191853999999999	0.1572622244218358
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.004191853999999999	0.1572622244218358
COCKAYNE SYNDROME	0.0041877189999999995	0.15710709514061932
CITRULLINEMIA TYPE I	0.0041877189999999995	0.15710709514061932
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.0041877189999999995	0.15710709514061932
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.0041877189999999995	0.15710709514061932
CHOREOACANTHOCYTOSIS	0.0041877189999999995	0.15710709514061932
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.0041877189999999995	0.15710709514061932
THYROID ECTOPIA	0.004116984	0.1544533902538369
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.004116984	0.1544533902538369
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.004116984	0.1544533902538369
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.004116984	0.1544533902538369
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.004116984	0.1544533902538369
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.004116984	0.1544533902538369
FAMILIAL THYROID DYSHORMONOGENESIS	0.004116984	0.1544533902538369
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.004116984	0.1544533902538369
CONGENITAL HYPOTHYROIDISM	0.004116984	0.1544533902538369
300270 ADRENOMYODYSTROPHY	0.004116984	0.1544533902538369
FLOATING-HARBOR SYNDROME	0.004116984	0.1544533902538369
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.004116984	0.1544533902538369
NIEMANN-PICK DISEASE, TYPE A	0.004116984	0.1544533902538369
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.004116984	0.1544533902538369
THYROID HEMIAGENESIS	0.004116984	0.1544533902538369
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.004116984	0.1544533902538369
THYROID HYPOPLASIA	0.004116984	0.1544533902538369
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.004116984	0.1544533902538369
PROPIONIC ACIDEMIA	0.004116984	0.1544533902538369
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.004112849	0.15429826097262048
TRISOMY 8P	0.004112849	0.15429826097262048
ADIPOSIS DOLOROSA	0.004112849	0.15429826097262048
PAROXYSMAL EXTREME PAIN DISORDER	0.004112849	0.15429826097262048
HEREDITARY FRUCTOSE INTOLERANCE	0.004112849	0.15429826097262048
PORPHYRIA VARIEGATA	0.004112849	0.15429826097262048
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.004112849	0.15429826097262048
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.004112849	0.15429826097262048
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.004112849	0.15429826097262048
ADDISON DISEASE	0.004112849	0.15429826097262048
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.004112849	0.15429826097262048
DDOST-CDG	0.004112849	0.15429826097262048
ACUTE ADRENAL INSUFFICIENCY	0.004112849	0.15429826097262048
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.004112849	0.15429826097262048
RETT SYNDROME, CONGENITAL VARIANT	0.004112849	0.15429826097262048
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.004112849	0.15429826097262048
PORPHYRIA	0.004112849	0.15429826097262048
HYPOPHOSPHATASIA, INFANTILE	0.004112849	0.15429826097262048
HEREDITARY COPROPORPHYRIA	0.004112849	0.15429826097262048
MOWAT-WILSON SYNDROME; MOWS	0.004112849	0.15429826097262048
ACUTE INTERMITTENT PORPHYRIA	0.004112849	0.15429826097262048
LYNCH SYNDROME	0.004112849	0.15429826097262048
FAMILIAL COLORECTAL CANCER TYPE X	0.004112849	0.15429826097262048
RETT SYNDROME; RTT	0.004112849	0.15429826097262048
AUTISM, SUSCEPTIBILITY TO, 18	0.004112849	0.15429826097262048
LOWE OCULOCEREBRORENAL SYNDROME	0.004112849	0.15429826097262048
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.004112849	0.15429826097262048
OCULOCEREBRORENAL SYNDROME OF LOWE	0.004112849	0.15429826097262048
PITT-HOPKINS SYNDROME	0.004112849	0.15429826097262048
FAMILIAL MEDITERRANEAN FEVER	0.004112849	0.15429826097262048
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.004112849	0.15429826097262048
KAPUR-TORIELLO SYNDROME	0.004112849	0.15429826097262048
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0038005199999999995	0.14258087928627175
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0038005199999999995	0.14258087928627175
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0038005199999999995	0.14258087928627175
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.0038005199999999995	0.14258087928627175
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.0038005199999999995	0.14258087928627175
TORIELLO-LACASSIE-DROSTE SYNDROME	0.0038005199999999995	0.14258087928627175
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0038005199999999995	0.14258087928627175
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.14210667514731748
ACETYLATION, SLOW	0.00378788	0.14210667514731748
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	0.14210667514731748
HYPOASCORBEMIA	0.00378788	0.14210667514731748
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.14210667514731748
HOOFT DISEASE	0.00378788	0.14210667514731748
GLUTATHIONURIA	0.00378788	0.14210667514731748
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.14210667514731748
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.14210667514731748
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.14210667514731748
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.14210667514731748
ETHANOLAMINOSIS	0.00378788	0.14210667514731748
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00378788	0.14210667514731748
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.14210667514731748
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.14210667514731748
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.14210667514731748
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.14210667514731748
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.14210667514731748
DERMATOLEUKODYSTROPHY	0.00378788	0.14210667514731748
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.14210667514731748
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00378788	0.14210667514731748
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.14210667514731748
CITRULLINE TRANSPORT DEFECT	0.00378788	0.14210667514731748
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.14210667514731748
CEPHALIN LIPIDOSIS	0.00378788	0.14210667514731748
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.14210667514731748
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.14210667514731748
LIPASE DEFICIENCY, COMBINED	0.00378788	0.14210667514731748
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	0.14210667514731748
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.14210667514731748
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.14210667514731748
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.14210667514731748
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.14210667514731748
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.14210667514731748
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.14210667514731748
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.14210667514731748
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.14210667514731748
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.14210667514731748
NEPHROSIALIDOSIS	0.00378788	0.14210667514731748
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.14210667514731748
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.14210667514731748
MYELOPEROXIDASE DEFICIENCY	0.00378788	0.14210667514731748
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.14210667514731748
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.14210667514731748
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.14210667514731748
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.14210667514731748
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.14210667514731748
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.14210667514731748
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.14210667514731748
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.14210667514731748
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.14210667514731748
LYMPHOKINE DEFICIENCY	0.00378788	0.14210667514731748
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.14210667514731748
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.14210667514731748
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.14210667514731748
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.14210667514731748
AREDYLD	0.00378788	0.14210667514731748
PARAOXONASE 1	0.00378788	0.14210667514731748
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.14210667514731748
PACMAN DYSPLASIA	0.00378788	0.14210667514731748
OVARIAN CANCER	0.00378788	0.14210667514731748
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.14210667514731748
APOLIPOPROTEIN(A)	0.00378788	0.14210667514731748
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.14210667514731748
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.14210667514731748
HYPERPROGLUCAGONEMIA	0.00378788	0.14210667514731748
HEINZ BODY ANEMIAS	0.00378788	0.14210667514731748
GLUTATHIONE REDUCTASE	0.00378788	0.14210667514731748
GLOMUVENOUS MALFORMATIONS	0.00378788	0.14210667514731748
FLOOD FACTOR DEFICIENCY	0.00378788	0.14210667514731748
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.14210667514731748
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.14210667514731748
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.14210667514731748
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.14210667514731748
COUMARIN RESISTANCE	0.00378788	0.14210667514731748
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.14210667514731748
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.14210667514731748
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.14210667514731748
CARBOXYLESTERASE 1	0.00378788	0.14210667514731748
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	0.14210667514731748
BEETURIA	0.00378788	0.14210667514731748
MACULAR CORNEAL DYSTROPHY	0.00378788	0.14210667514731748
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.14210667514731748
PERRY SYNDROME	0.00378788	0.14210667514731748
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.14210667514731748
LARON SYNDROME	0.00378788	0.14210667514731748
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.14210667514731748
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.14210667514731748
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.14210667514731748
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.14210667514731748
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.14210667514731748
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	0.14210667514731748
ALKAPTONURIA	0.00378788	0.14210667514731748
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.14210667514731748
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00378788	0.14210667514731748
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.14210667514731748
ZINC, ELEVATED PLASMA	0.00378788	0.14210667514731748
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.14210667514731748
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.14210667514731748
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.14210667514731748
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.14210667514731748
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.14210667514731748
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.14210667514731748
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.14210667514731748
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.14210667514731748
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.14210667514731748
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.14210667514731748
SPINAL ARACHNOIDITIS	0.00378788	0.14210667514731748
MYOPATHY, SPHEROID BODY	0.00378788	0.14210667514731748
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.14210667514731748
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.14210667514731748
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.14210667514731748
OSTEOGENIC SARCOMA	0.00378788	0.14210667514731748
T-SUBSTANCE ANOMALY	0.00378788	0.14210667514731748
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.14210667514731748
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.14210667514731748
SCHIZOPHRENIA 4	0.00378788	0.14210667514731748
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.14210667514731748
MACROCYTOSIS, FAMILIAL	0.00378788	0.14210667514731748
PENDRED SYNDROME	0.00378788	0.14210667514731748
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.14210667514731748
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.14210667514731748
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.14210667514731748
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.14210667514731748
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.14210667514731748
OSTEOMESOPYKNOSIS	0.00378788	0.14210667514731748
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.14210667514731748
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.14210667514731748
ALAND ISLAND EYE DISEASE	0.00378788	0.14210667514731748
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.14210667514731748
ONCOCYTOMA	0.00378788	0.14210667514731748
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.14210667514731748
XM SYSTEM	0.00378788	0.14210667514731748
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.14210667514731748
XANTHINURIA, TYPE I	0.00378788	0.14210667514731748
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.14210667514731748
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.14210667514731748
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.14210667514731748
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.14210667514731748
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.14210667514731748
PREMATURE OVARIAN FAILURE 1	0.00378788	0.14210667514731748
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.14210667514731748
BARTTER SYNDROME	0.00378788	0.14210667514731748
DELETED IN AZOOSPERMIA	0.00378788	0.14210667514731748
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.14210667514731748
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.14210667514731748
GONADOBLASTOMA	0.00378788	0.14210667514731748
TRISOMY 18-LIKE SYNDROME	0.00378788	0.14210667514731748
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.14210667514731748
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.14210667514731748
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.14210667514731748
PROGESTERONE RESISTANCE	0.00378788	0.14210667514731748
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.14210667514731748
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.14210667514731748
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.14210667514731748
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.14210667514731748
FINGERPRINT BODY MYOPATHY	0.00378788	0.14210667514731748
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.14210667514731748
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00378788	0.14210667514731748
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.14210667514731748
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00378788	0.14210667514731748
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.14210667514731748
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.14210667514731748
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.14210667514731748
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.14210667514731748
PITUITARY DWARFISM IV	0.00378788	0.14210667514731748
CALVARIAL HYPEROSTOSIS	0.00378788	0.14210667514731748
PYGMY	0.00378788	0.14210667514731748
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00378788	0.14210667514731748
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.14210667514731748
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00378788	0.14210667514731748
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.14210667514731748
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00378788	0.14210667514731748
DERMATITIS, ATOPIC	0.00378788	0.14210667514731748
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.14210667514731748
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.14210667514731748
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.14210667514731748
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.14210667514731748
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.14210667514731748
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.14210667514731748
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.14210667514731748
ICHTHYOSIS, X-LINKED	0.00378788	0.14210667514731748
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.14210667514731748
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.14210667514731748
JOUBERT SYNDROME 1	0.003653974	0.13708303753412046
CEREBROFACIOARTICULAR SYNDROME	0.003653974	0.13708303753412046
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.003653974	0.13708303753412046
JOUBERT SYNDROME 14	0.003653974	0.13708303753412046
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0036539739999999995	0.13708303753412046
OROFACIODIGITAL SYNDROME TYPE 1	0.0036498389999999998	0.13692790825290402
OCULODENTODIGITAL DYSPLASIA; ODDD	0.0036498389999999998	0.13692790825290402
OCULODENTODIGITAL DYSPLASIA	0.0036498389999999998	0.13692790825290402
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.0036498389999999998	0.13692790825290402
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.0036498389999999998	0.13692790825290402
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.0036498389999999998	0.13692790825290402
MILLER-DIEKER SYNDROME	0.0036498389999999998	0.13692790825290402
CLASSIC GALACTOSEMIA	0.0036462999999999995	0.13679513859722686
CHIARI MALFORMATION TYPE II	0.0036462999999999995	0.13679513859722686
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0036462999999999995	0.13679513859722686
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.00357143	0.133986304429228
TOWNES-BROCKS SYNDROME	0.00357143	0.133986304429228
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00357143	0.133986304429228
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00357143	0.133986304429228
FOODBORNE BOTULISM	0.00357143	0.133986304429228
ATTRV30M AMYLOIDOSIS	0.00357143	0.133986304429228
SHEEHAN SYNDROME	0.00357143	0.133986304429228
HINMAN SYNDROME	0.00357143	0.133986304429228
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00357143	0.133986304429228
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00357143	0.133986304429228
VISCERAL MYOPATHY; VSCM	0.00357143	0.133986304429228
PARKINSON DISEASE, LATE-ONSET; PD	0.00357143	0.133986304429228
GRFOMA	0.00357143	0.133986304429228
WAARDENBURG-SHAH SYNDROME	0.00357143	0.133986304429228
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00357143	0.133986304429228
CAP POLYPOSIS	0.00357143	0.133986304429228
SECONDARY SHORT BOWEL SYNDROME	0.00357143	0.133986304429228
PANHYPOPITUITARISM	0.00357143	0.133986304429228
PORPHYRIA VARIEGATA	0.00357143	0.133986304429228
PRIMARY PERITONEAL CARCINOMA	0.00357143	0.133986304429228
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00357143	0.133986304429228
INHALATIONAL BOTULISM	0.00357143	0.133986304429228
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00357143	0.133986304429228
PARATHYROID CARCINOMA	0.00357143	0.133986304429228
PERITONEAL CYSTIC MESOTHELIOMA	0.00357143	0.133986304429228
YOUNG-ONSET PARKINSON DISEASE	0.00357143	0.133986304429228
IATROGENIC BOTULISM	0.00357143	0.133986304429228
MALT LYMPHOMA	0.00357143	0.133986304429228
KAPUR-TORIELLO SYNDROME	0.00357143	0.133986304429228
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00357143	0.133986304429228
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00357143	0.133986304429228
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00357143	0.133986304429228
PUDENDAL NEURALGIA	0.00357143	0.133986304429228
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00357143	0.133986304429228
ANAL SPHINCTER DYSPLASIA; ASDP	0.00357143	0.133986304429228
PRUNE BELLY SYNDROME	0.00357143	0.133986304429228
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00357143	0.133986304429228
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00357143	0.133986304429228
RHEUMATIC FEVER	0.00357143	0.133986304429228
LIDDLE SYNDROME	0.00357143	0.133986304429228
NK-CELL ENTEROPATHY	0.00357143	0.133986304429228
PPOMA	0.00357143	0.133986304429228
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00357143	0.133986304429228
UROFACIAL SYNDROME 2	0.00357143	0.133986304429228
PSEUDOMYXOMA PERITONEI	0.00357143	0.133986304429228
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00357143	0.133986304429228
ADIPOSIS DOLOROSA	0.00357143	0.133986304429228
MYXEDEMA	0.00357143	0.133986304429228
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.00357143	0.133986304429228
PRIMARY PARATHYROID HYPERPLASIA	0.00357143	0.133986304429228
OCHOA SYNDROME	0.00357143	0.133986304429228
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00357143	0.133986304429228
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00357143	0.133986304429228
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00357143	0.133986304429228
UROFACIAL SYNDROME	0.00357143	0.133986304429228
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00357143	0.133986304429228
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00357143	0.133986304429228
13Q12.3 MICRODELETION SYNDROME	0.00357143	0.133986304429228
GLUCAGONOMA	0.00357143	0.133986304429228
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00357143	0.133986304429228
SOMATOSTATINOMA	0.00357143	0.133986304429228
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00357143	0.133986304429228
WOUND BOTULISM	0.00357143	0.133986304429228
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00357143	0.133986304429228
HIRSCHSPRUNG DISEASE	0.00357143	0.133986304429228
BOTULISM	0.00357143	0.133986304429228
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00357143	0.133986304429228
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00357143	0.133986304429228
THYROTOXIC PERIODIC PARALYSIS	0.00357143	0.133986304429228
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00357143	0.133986304429228
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00357143	0.133986304429228
LAMBERT-EATON MYASTHENIC SYNDROME	0.00357143	0.133986304429228
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00357143	0.133986304429228
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00357143	0.133986304429228
FG SYNDROME 2; FGS2	0.00357143	0.133986304429228
PURE AUTONOMIC FAILURE	0.00357143	0.133986304429228
INFANT BOTULISM	0.00357143	0.133986304429228
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00357143	0.133986304429228
MULTIPLE SYSTEM ATROPHY	0.00357143	0.133986304429228
GASTROINTESTINAL STROMAL TUMOR	0.00357143	0.133986304429228
POLYMYOSITIS	0.00357143	0.133986304429228
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00357143	0.133986304429228
JUVENILE DERMATOMYOSITIS	0.00357143	0.133986304429228
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0032561729999999994	0.12215907545499492
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0032561729999999994	0.12215907545499492
HELSMOORTEL-VAN DER AA SYNDROME	0.0032561729999999994	0.12215907545499492
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.0032561729999999994	0.12215907545499492
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0032561729999999994	0.12215907545499492
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.0032561729999999994	0.12215907545499492
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0032561729999999994	0.12215907545499492
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.0032561729999999994	0.12215907545499492
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.0032561729999999994	0.12215907545499492
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0032561729999999994	0.12215907545499492
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0032561729999999994	0.12215907545499492
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0032561729999999994	0.12215907545499492
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0032561729999999994	0.12215907545499492
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.0032561729999999994	0.12215907545499492
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0032561729999999994	0.12215907545499492
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0032561729999999994	0.12215907545499492
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.0032561729999999994	0.12215907545499492
ZTTK SYNDROME; ZTTKS	0.0032561729999999994	0.12215907545499492
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.0032561729999999994	0.12215907545499492
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0032561729999999994	0.12215907545499492
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.0032561729999999994	0.12215907545499492
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0032561729999999994	0.12215907545499492
COFFIN-SIRIS SYNDROME 5	0.0032561729999999994	0.12215907545499492
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.0032561729999999994	0.12215907545499492
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0032561729999999994	0.12215907545499492
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0032561729999999994	0.12215907545499492
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.0032561729999999994	0.12215907545499492
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0032561729999999994	0.12215907545499492
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0032561729999999994	0.12215907545499492
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0032561729999999994	0.12215907545499492
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0032561729999999994	0.12215907545499492
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0032561729999999994	0.12215907545499492
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0032561729999999994	0.12215907545499492
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0032561729999999994	0.12215907545499492
COFFIN-SIRIS SYNDROME 2; CSS2	0.0032561729999999994	0.12215907545499492
COFFIN-SIRIS SYNDROME 3; CSS3	0.0032561729999999994	0.12215907545499492
COFFIN-SIRIS SYNDROME 4; CSS4	0.0032561729999999994	0.12215907545499492
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0032561729999999994	0.12215907545499492
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0032561729999999994	0.12215907545499492
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0032561729999999994	0.12215907545499492
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.0032561729999999994	0.12215907545499492
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0032561729999999994	0.12215907545499492
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.0032561729999999994	0.12215907545499492
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0032561729999999994	0.12215907545499492
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.0032561729999999994	0.12215907545499492
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.0032561729999999994	0.12215907545499492
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0032561729999999994	0.12215907545499492
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0032561729999999994	0.12215907545499492
STT3B-CDG	0.0032561729999999994	0.12215907545499492
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.0032561729999999994	0.12215907545499492
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0032561729999999994	0.12215907545499492
WIEACKER-WOLFF SYNDROME	0.0032561729999999994	0.12215907545499492
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.0032561729999999994	0.12215907545499492
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.0032561729999999994	0.12215907545499492
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.0032561729999999994	0.12215907545499492
GENITOPATELLAR SYNDROME	0.0032561729999999994	0.12215907545499492
STT3A-CDG	0.0032561729999999994	0.12215907545499492
PIERPONT SYNDROME	0.0032561729999999994	0.12215907545499492
BOHRING-OPITZ SYNDROME	0.0032561729999999994	0.12215907545499492
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0032561729999999994	0.12215907545499492
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0032561729999999994	0.12215907545499492
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.0032561729999999994	0.12215907545499492
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.0032561729999999994	0.12215907545499492
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.0032561729999999994	0.12215907545499492
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0032561729999999994	0.12215907545499492
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.0032561729999999994	0.12215907545499492
GAUCHER DISEASE, TYPE II	0.0032561729999999994	0.12215907545499492
KBG SYNDROME	0.0032561729999999994	0.12215907545499492
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.0032561729999999994	0.12215907545499492
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.0032561729999999994	0.12215907545499492
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.0032561729999999994	0.12215907545499492
BOHRING-OPITZ SYNDROME	0.0032561729999999994	0.12215907545499492
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0032561729999999994	0.12215907545499492
17Q12 MICRODELETION SYNDROME	0.0032561729999999994	0.12215907545499492
SSR4-CDG	0.0032561729999999994	0.12215907545499492
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.0032561729999999994	0.12215907545499492
NON-DISTAL MONOSOMY 10Q	0.0031084199999999998	0.11661595170951156
LAURENCE-MOON SYNDROME	0.0031084199999999998	0.11661595170951156
JOUBERT SYNDROME 3; JBTS3	0.0031084199999999998	0.11661595170951156
20Q11.2 MICRODUPLICATION SYNDROME	0.002718293	0.1019798885672796
DISTAL MONOSOMY 1Q	0.002718293	0.1019798885672796
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.002718293	0.1019798885672796
OCULOECTODERMAL SYNDROME; OES	0.002718293	0.1019798885672796
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.002718293	0.1019798885672796
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.002718293	0.1019798885672796
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.002718293	0.1019798885672796
MATERNAL PHENYLKETONURIA	0.002718293	0.1019798885672796
MONOSOMY 9P	0.002718293	0.1019798885672796
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.002718293	0.1019798885672796
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.002718293	0.1019798885672796
TEMPLE-BARAITSER SYNDROME; TMBTS	0.002718293	0.1019798885672796
DISTAL TRISOMY 17Q	0.002718293	0.1019798885672796
RING CHROMOSOME 22 SYNDROME	0.002718293	0.1019798885672796
20P12.3 MICRODELETION SYNDROME	0.002718293	0.1019798885672796
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.002718293	0.1019798885672796
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.002718293	0.1019798885672796
15Q24 MICRODELETION SYNDROME	0.002718293	0.1019798885672796
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.002718293	0.1019798885672796
KOOLEN-DE VRIES SYNDROME	0.002718293	0.1019798885672796
KOOLEN-DE VRIES SYNDROME; KDVS	0.002718293	0.1019798885672796
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.002718293	0.1019798885672796
SIALURIA	0.002718293	0.1019798885672796
22Q11.2 MICRODUPLICATION SYNDROME	0.002718293	0.1019798885672796
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.002718293	0.1019798885672796
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.002718293	0.1019798885672796
MONOSOMY 18Q	0.002718293	0.1019798885672796
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.002718293	0.1019798885672796
TRISOMY X	0.002718293	0.1019798885672796
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.002718293	0.1019798885672796
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.002718293	0.1019798885672796
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.002718293	0.1019798885672796
COFFIN-SIRIS SYNDROME	0.002718293	0.1019798885672796
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002718293	0.1019798885672796
10Q22.3Q23.3 MICRODELETION SYNDROME	0.002718293	0.1019798885672796
SIMPSON-GOLABI-BEHMEL SYNDROME	0.002718293	0.1019798885672796
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.002718293	0.1019798885672796
2Q31.1 MICRODELETION SYNDROME	0.002718293	0.1019798885672796
1Q21.1 MICRODELETION SYNDROME	0.002718293	0.1019798885672796
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.002718293	0.1019798885672796
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.002718293	0.1019798885672796
WEAVER SYNDROME	0.002718293	0.1019798885672796
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.002718293	0.1019798885672796
LATHOSTEROLOSIS	0.002718293	0.1019798885672796
XQ25 DUPLICATION SYNDROME	0.002718293	0.1019798885672796
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.002718293	0.1019798885672796
SMITH-LEMLI-OPITZ SYNDROME	0.002718293	0.1019798885672796
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.002718293	0.1019798885672796
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.002718293	0.1019798885672796
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.002718293	0.1019798885672796
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.002718293	0.1019798885672796
PEHO SYNDROME; PEHO	0.002718293	0.1019798885672796
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.002718293	0.1019798885672796
XQ25 MICRODUPLICATION SYNDROME	0.002718293	0.1019798885672796
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.002718293	0.1019798885672796
C SYNDROME	0.002718293	0.1019798885672796
POTOCKI-SHAFFER SYNDROME	0.002718293	0.1019798885672796
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.002718293	0.1019798885672796
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.002718293	0.1019798885672796
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.002718293	0.1019798885672796
INFANTILE SIALIC ACID STORAGE DISEASE	0.002718293	0.1019798885672796
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.002718293	0.1019798885672796
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.002718293	0.1019798885672796
AL KAISSI SYNDROME; ALKAS	0.002718293	0.1019798885672796
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.002718293	0.1019798885672796
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.002718293	0.1019798885672796
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.002718293	0.1019798885672796
MAN1B1-CDG	0.002718293	0.1019798885672796
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.002718293	0.1019798885672796
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.002718293	0.1019798885672796
19P13.12 MICRODELETION SYNDROME	0.002718293	0.1019798885672796
WITTEVEEN-KOLK SYNDROME	0.002718293	0.1019798885672796
MENTAL RETARDATION, X-LINKED 91; MRX91	0.002718293	0.1019798885672796
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.002718293	0.1019798885672796
8P23.1 MICRODELETION SYNDROME	0.002718293	0.1019798885672796
6Q25 MICRODELETION SYNDROME	0.002718293	0.1019798885672796
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0027147539999999998	0.10184711891160246
TONNE-KALSCHEUER SYNDROME; TOKAS	0.0027147539999999998	0.10184711891160246
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.0027147539999999998	0.10184711891160246
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0027147539999999998	0.10184711891160246
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0027147539999999998	0.10184711891160246
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.0027147539999999998	0.10184711891160246
HURLER SYNDROME	0.0027147539999999998	0.10184711891160246
SPINOCEREBELLAR ATAXIA TYPE 7	0.0027147539999999998	0.10184711891160246
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.0027147539999999998	0.10184711891160246
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.0027147539999999998	0.10184711891160246
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.0027147539999999998	0.10184711891160246
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0027147539999999998	0.10184711891160246
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.0027147539999999998	0.10184711891160246
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0027147539999999998	0.10184711891160246
POPOV-CHANG SYNDROME; POPCHAS	0.0027147539999999998	0.10184711891160246
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0027147539999999998	0.10184711891160246
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0027147539999999998	0.10184711891160246
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.0027147539999999998	0.10184711891160246
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.0027147539999999998	0.10184711891160246
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.0027147539999999998	0.10184711891160246
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0027147539999999998	0.10184711891160246
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0027147539999999998	0.10184711891160246
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.0027147539999999998	0.10184711891160246
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0027147539999999998	0.10184711891160246
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.0027147539999999998	0.10184711891160246
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0027147539999999998	0.10184711891160246
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.0027147539999999998	0.10184711891160246
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0027147539999999998	0.10184711891160246
AURICULOCONDYLAR SYNDROME	0.0027147539999999998	0.10184711891160246
GALACTOSE EPIMERASE DEFICIENCY	0.0027147539999999998	0.10184711891160246
TYSHCHENKO SYNDROME	0.0027147539999999998	0.10184711891160246
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0027147539999999998	0.10184711891160246
OROFACIODIGITAL SYNDROME TYPE 4	0.0027147539999999998	0.10184711891160246
2Q32Q33 MICRODELETION SYNDROME	0.0027147539999999998	0.10184711891160246
MARDEN-WALKER SYNDROME	0.0027147539999999998	0.10184711891160246
PRIMARY CONGENITAL HYPOTHYROIDISM	0.0027147539999999998	0.10184711891160246
EAR-PATELLA-SHORT STATURE SYNDROME	0.0027147539999999998	0.10184711891160246
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.0027147539999999998	0.10184711891160246
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0027106189999999996	0.10169198963038599
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.0027106189999999996	0.10169198963038599
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.0027106189999999996	0.10169198963038599
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.0027106189999999996	0.10169198963038599
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0027106189999999996	0.10169198963038599
16Q24.3 MICRODELETION SYNDROME	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0027106189999999996	0.10169198963038599
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0027106189999999996	0.10169198963038599
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0027106189999999996	0.10169198963038599
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0027106189999999996	0.10169198963038599
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0027106189999999996	0.10169198963038599
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.0027106189999999996	0.10169198963038599
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.0027106189999999996	0.10169198963038599
CRISPONI SYNDROME	0.0027106189999999996	0.10169198963038599
SMITH-KINGSMORE SYNDROME; SKS	0.0027106189999999996	0.10169198963038599
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.0027106189999999996	0.10169198963038599
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.0027106189999999996	0.10169198963038599
KABUKI SYNDROME	0.0027106189999999996	0.10169198963038599
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0027106189999999996	0.10169198963038599
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0027106189999999996	0.10169198963038599
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.0027106189999999996	0.10169198963038599
17Q24.2 MICRODELETION SYNDROME	0.0027106189999999996	0.10169198963038599
ACUTE BILIRUBIN ENCEPHALOPATHY	0.0027106189999999996	0.10169198963038599
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0027106189999999996	0.10169198963038599
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.0027106189999999996	0.10169198963038599
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.0027106189999999996	0.10169198963038599
5Q14.3 MICRODELETION SYNDROME	0.0027106189999999996	0.10169198963038599
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0027106189999999996	0.10169198963038599
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.0027106189999999996	0.10169198963038599
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.0027106189999999996	0.10169198963038599
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.0027106189999999996	0.10169198963038599
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.0027106189999999996	0.10169198963038599
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.0027106189999999996	0.10169198963038599
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.0027106189999999996	0.10169198963038599
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.002564073	0.09619414787823474
LEIGH SYNDROME; LS	0.002564073	0.09619414787823474
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.002564073	0.09619414787823474
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.002564073	0.09619414787823474
GALACTOSEMIA	0.002564073	0.09619414787823474
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.002564073	0.09619414787823474
ELEJALDE DISEASE	0.002564073	0.09619414787823474
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.002564073	0.09619414787823474
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.002564073	0.09619414787823474
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.002564073	0.09619414787823474
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.002564073	0.09619414787823474
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.002564073	0.09619414787823474
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.002564073	0.09619414787823474
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.002564073	0.09619414787823474
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.002564073	0.09619414787823474
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.002564073	0.09619414787823474
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.002564073	0.09619414787823474
CENTRAL BILATERAL MACROGYRIA	0.002564073	0.09619414787823474
MAPLE SYRUP URINE DISEASE	0.002564073	0.09619414787823474
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.002564073	0.09619414787823474
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.002564073	0.09619414787823474
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.002564073	0.09619414787823474
PELIZAEUS-MERZBACHER DISEASE	0.002564073	0.09619414787823474
EAST SYNDROME	0.002564073	0.09619414787823474
FREE SIALIC ACID STORAGE DISEASE	0.002564073	0.09619414787823474
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.002564073	0.09619414787823474
HSD10 DISEASE	0.002564073	0.09619414787823474
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.002564073	0.09619414787823474
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.002564073	0.09619414787823474
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.002564073	0.09619414787823474
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.002564073	0.09619414787823474
MENTAL RETARDATION, X-LINKED 104; MRX104	0.002564073	0.09619414787823474
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.002564073	0.09619414787823474
CHROMOSOME 1P35 DELETION SYNDROME	0.002564073	0.09619414787823474
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.002564073	0.09619414787823474
MYHRE SYNDROME	0.002564073	0.09619414787823474
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.002564073	0.09619414787823474
ARGININOSUCCINIC ACIDURIA	0.002564073	0.09619414787823474
TAY-SACHS DISEASE	0.002564073	0.09619414787823474
MEVALONIC ACIDURIA	0.002564073	0.09619414787823474
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.002564073	0.09619414787823474
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.002564073	0.09619414787823474
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.002564073	0.09619414787823474
SIALIDOSIS TYPE 2	0.002564073	0.09619414787823474
SULFOCYSTEINURIA	0.002564073	0.09619414787823474
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.002564073	0.09619414787823474
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.002564073	0.09619414787823474
JOUBERT SYNDROME	0.002564073	0.09619414787823474
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.002564073	0.09619414787823474
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.002564073	0.09619414787823474
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.002564073	0.09619414787823474
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.002564073	0.09619414787823474
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.002564073	0.09619414787823474
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.002564073	0.09619414787823474
NIEMANN-PICK DISEASE TYPE C	0.002564073	0.09619414787823474
CEDNIK SYNDROME	0.002564073	0.09619414787823474
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.002564073	0.09619414787823474
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.002564073	0.09619414787823474
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.002564073	0.09619414787823474
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.002564073	0.09619414787823474
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.002564073	0.09619414787823474
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.002564073	0.09619414787823474
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.002564073	0.09619414787823474
HARTNUP DISEASE	0.002564073	0.09619414787823474
CITRULLINEMIA, CLASSIC	0.002564073	0.09619414787823474
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.002564073	0.09619414787823474
FOLATE MALABSORPTION, HEREDITARY	0.002564073	0.09619414787823474
INFANTILE REFSUM DISEASE	0.002564073	0.09619414787823474
COACH SYNDROME	0.002564073	0.09619414787823474
COWDEN SYNDROME	0.002564073	0.09619414787823474
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.002564073	0.09619414787823474
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.002564073	0.09619414787823474
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.002564073	0.09619414787823474
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.002564073	0.09619414787823474
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.002564073	0.09619414787823474
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.002564073	0.09619414787823474
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.002564073	0.09619414787823474
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.002564073	0.09619414787823474
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.002564073	0.09619414787823474
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.002564073	0.09619414787823474
CHÃ‰DIAK-HIGASHI SYNDROME	0.002564073	0.09619414787823474
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.002564073	0.09619414787823474
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.002564073	0.09619414787823474
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.002564073	0.09619414787823474
GRISCELLI SYNDROME TYPE 1	0.002564073	0.09619414787823474
SRD5A3-CDG	0.002564073	0.09619414787823474
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.002564073	0.09619414787823474
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0021768739999999996	0.08166793202388713
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0021768739999999996	0.08166793202388713
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0021768739999999996	0.08166793202388713
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0021768739999999996	0.08166793202388713
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0021768739999999996	0.08166793202388713
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0021768739999999996	0.08166793202388713
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0021768739999999996	0.08166793202388713
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0021768739999999996	0.08166793202388713
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0021768739999999996	0.08166793202388713
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0021768739999999996	0.08166793202388713
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.0021768739999999996	0.08166793202388713
ICF SYNDROME	0.0021768739999999996	0.08166793202388713
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.0021768739999999996	0.08166793202388713
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0021768739999999996	0.08166793202388713
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0021768739999999996	0.08166793202388713
WARSAW BREAKAGE SYNDROME; WABS	0.0021768739999999996	0.08166793202388713
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0021768739999999996	0.08166793202388713
JOUBERT SYNDROME 10	0.0021768739999999996	0.08166793202388713
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0021768739999999996	0.08166793202388713
OGDEN SYNDROME; OGDNS	0.0021768739999999996	0.08166793202388713
NOONAN SYNDROME 6; NS6	0.0021768739999999996	0.08166793202388713
COSTELLO SYNDROME; CSTLO	0.0021768739999999996	0.08166793202388713
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0021768739999999996	0.08166793202388713
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.0021768739999999996	0.08166793202388713
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.0021768739999999996	0.08166793202388713
OROFACIODIGITAL SYNDROME VI	0.0021768739999999996	0.08166793202388713
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.0021768739999999996	0.08166793202388713
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0021768739999999996	0.08166793202388713
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0021768739999999996	0.08166793202388713
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.0021768739999999996	0.08166793202388713
LIG4 SYNDROME	0.0021768739999999996	0.08166793202388713
LYMPHEDEMA, HEREDITARY, III	0.0021768739999999996	0.08166793202388713
BARATELA-SCOTT SYNDROME	0.0021768739999999996	0.08166793202388713
HARTSFIELD SYNDROME; HRTFDS	0.0021768739999999996	0.08166793202388713
LATERAL MENINGOCELE SYNDROME	0.0021768739999999996	0.08166793202388713
DISTAL MONOSOMY 6P	0.0021768739999999996	0.08166793202388713
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0021768739999999996	0.08166793202388713
CHROMOSOME 16Q22 DELETION SYNDROME	0.0021768739999999996	0.08166793202388713
ROTHMUND-THOMSON SYNDROME	0.0021768739999999996	0.08166793202388713
8Q12 MICRODUPLICATION SYNDROME	0.0021768739999999996	0.08166793202388713
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0021768739999999996	0.08166793202388713
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.0021768739999999996	0.08166793202388713
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.0021768739999999996	0.08166793202388713
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0021768739999999996	0.08166793202388713
FANCONI ANEMIA	0.0021768739999999996	0.08166793202388713
OCULOSKELETODENTAL SYNDROME; OCSKD	0.0021768739999999996	0.08166793202388713
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0021768739999999996	0.08166793202388713
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.0021768739999999996	0.08166793202388713
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.0021768739999999996	0.08166793202388713
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.0021768739999999996	0.08166793202388713
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0021768739999999996	0.08166793202388713
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0021768739999999996	0.08166793202388713
NOONAN SYNDROME 3; NS3	0.0021768739999999996	0.08166793202388713
14Q22Q23 MICRODELETION SYNDROME	0.0021768739999999996	0.08166793202388713
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0021768739999999996	0.08166793202388713
CODAS SYNDROME	0.0021768739999999996	0.08166793202388713
6Q16 MICRODELETION SYNDROME	0.0021768739999999996	0.08166793202388713
OPITZ G/BBB SYNDROME	0.0021768739999999996	0.08166793202388713
FETAL HYDANTOIN SYNDROME	0.0021768739999999996	0.08166793202388713
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0021768739999999996	0.08166793202388713
CHARGE SYNDROME	0.0021768739999999996	0.08166793202388713
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.0021768739999999996	0.08166793202388713
TRISOMY 12P	0.0021768739999999996	0.08166793202388713
17Q21.31 MICRODUPLICATION SYNDROME	0.0021768739999999996	0.08166793202388713
MONOSOMY 18P	0.0021768739999999996	0.08166793202388713
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0021768739999999996	0.08166793202388713
NOONAN SYNDROME 5; NS5	0.0021768739999999996	0.08166793202388713
AARSKOG-SCOTT SYNDROME	0.0021768739999999996	0.08166793202388713
TOLUENE EMBRYOPATHY	0.0021768739999999996	0.08166793202388713
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0021768739999999996	0.08166793202388713
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0021768739999999996	0.08166793202388713
TETRASOMY X	0.0021768739999999996	0.08166793202388713
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.0021768739999999996	0.08166793202388713
FETAL TRIMETHADIONE SYNDROME	0.0021768739999999996	0.08166793202388713
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.0021768739999999996	0.08166793202388713
DIAPHANOSPONDYLODYSOSTOSIS	0.0021768739999999996	0.08166793202388713
TRISOMY 18	0.0021768739999999996	0.08166793202388713
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0021768739999999996	0.08166793202388713
MONOSOMY 13Q34	0.0021768739999999996	0.08166793202388713
FRONTOOCULAR SYNDROME	0.0021768739999999996	0.08166793202388713
VASCULAR EHLERS-DANLOS SYNDROME	0.0021768739999999996	0.08166793202388713
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.0021768739999999996	0.08166793202388713
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0021768739999999996	0.08166793202388713
CHROMOSOME 9P DELETION SYNDROME	0.0021768739999999996	0.08166793202388713
FETAL ALCOHOL SYNDROME	0.0021768739999999996	0.08166793202388713
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.0021768739999999996	0.08166793202388713
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0021768739999999996	0.08166793202388713
CARDIOFACIOCUTANEOUS SYNDROME	0.0021768739999999996	0.08166793202388713
PHENOBARBITAL EMBRYOPATHY	0.0021768739999999996	0.08166793202388713
HADZISELIMOVIC SYNDROME	0.0021768739999999996	0.08166793202388713
PSEUDOAMINOPTERIN SYNDROME	0.0021768739999999996	0.08166793202388713
DE BARSY SYNDROME	0.0021768739999999996	0.08166793202388713
DISTAL MONOSOMY 9P	0.0021768739999999996	0.08166793202388713
KNOBLOCH SYNDROME	0.002172739	0.08151280274267068
TETRASOMY 18P	0.002172739	0.08151280274267068
HENNEKAM SYNDROME	0.002172739	0.08151280274267068
DISTAL MONOSOMY 3P	0.002172739	0.08151280274267068
CHIME SYNDROME	0.002172739	0.08151280274267068
OHDO SYNDROME	0.002172739	0.08151280274267068
POTOCKI-SHAFFER SYNDROME	0.002172739	0.08151280274267068
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.002172739	0.08151280274267068
FOUNTAIN SYNDROME	0.002172739	0.08151280274267068
DUBOWITZ SYNDROME	0.002172739	0.08151280274267068
MARDEN-WALKER SYNDROME	0.002172739	0.08151280274267068
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.002172739	0.08151280274267068
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.002172739	0.08151280274267068
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.002172739	0.08151280274267068
NON-DISTAL MONOSOMY 20Q	0.002172739	0.08151280274267068
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.002172739	0.08151280274267068
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.002172739	0.08151280274267068
ZELLWEGER SYNDROME	0.002172739	0.08151280274267068
MECKEL SYNDROME, TYPE 10; MKS10	0.002172739	0.08151280274267068
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.002172739	0.08151280274267068
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.002172739	0.08151280274267068
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.002172739	0.08151280274267068
CHROMOSOME 18Q DELETION SYNDROME	0.002172739	0.08151280274267068
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.002172739	0.08151280274267068
HALL-RIGGS SYNDROME	0.002172739	0.08151280274267068
SAETHRE-CHOTZEN SYNDROME	0.002172739	0.08151280274267068
RENPENNING SYNDROME	0.002172739	0.08151280274267068
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.002172739	0.08151280274267068
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.002172739	0.08151280274267068
WOLCOTT-RALLISON SYNDROME	0.002172739	0.08151280274267068
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.002172739	0.08151280274267068
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.002172739	0.08151280274267068
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.002172739	0.08151280274267068
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.002172739	0.08151280274267068
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.002172739	0.08151280274267068
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.002172739	0.08151280274267068
OROFACIODIGITAL SYNDROME I; OFD1	0.002172739	0.08151280274267068
COFFIN-LOWRY SYNDROME	0.002172739	0.08151280274267068
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.002172739	0.08151280274267068
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.002172739	0.08151280274267068
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.002172739	0.08151280274267068
ZUNICH NEUROECTODERMAL SYNDROME	0.002172739	0.08151280274267068
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.002172739	0.08151280274267068
MOMO SYNDROME	0.002172739	0.08151280274267068
ACROCALLOSAL SYNDROME; ACLS	0.002172739	0.08151280274267068
20Q13.33 MICRODELETION SYNDROME	0.002172739	0.08151280274267068
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.002172739	0.08151280274267068
RENPENNING SYNDROME 1; RENS1	0.002172739	0.08151280274267068
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.0021691999999999996	0.08138003308699353
ADULT-ONSET NEMALINE MYOPATHY	0.0021691999999999996	0.08138003308699353
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.0021691999999999996	0.08138003308699353
CEREBROCOSTOMANDIBULAR SYNDROME	0.0021691999999999996	0.08138003308699353
STUVE-WIEDEMANN SYNDROME	0.0021691999999999996	0.08138003308699353
PEROXISOME BIOGENESIS DISORDER 11B	0.0021691999999999996	0.08138003308699353
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.0021691999999999996	0.08138003308699353
ISOTRETINOIN-LIKE SYNDROME	0.0021691999999999996	0.08138003308699353
TYPICAL NEMALINE MYOPATHY	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0021691999999999996	0.08138003308699353
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0021691999999999996	0.08138003308699353
LARYNGOTRACHEAL ANGIOMA	0.0021691999999999996	0.08138003308699353
CHOANAL ATRESIA	0.0021691999999999996	0.08138003308699353
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.0021691999999999996	0.08138003308699353
FONTAINE PROGEROID SYNDROME; FPS	0.0021691999999999996	0.08138003308699353
SANDIFER SYNDROME	0.0021691999999999996	0.08138003308699353
CHARGE SYNDROME	0.0021691999999999996	0.08138003308699353
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.0021691999999999996	0.08138003308699353
NEONATAL MARFAN SYNDROME	0.0021691999999999996	0.08138003308699353
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0021691999999999996	0.08138003308699353
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.0021691999999999996	0.08138003308699353
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.0021691999999999996	0.08138003308699353
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0021691999999999996	0.08138003308699353
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.0021691999999999996	0.08138003308699353
BETA-THALASSEMIA MAJOR	0.0021691999999999996	0.08138003308699353
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.0021691999999999996	0.08138003308699353
FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.08138003308699353
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.0021691999999999996	0.08138003308699353
CHILDHOOD APRAXIA OF SPEECH	0.0021691999999999996	0.08138003308699353
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0021691999999999996	0.08138003308699353
TRIGEMINAL NEURALGIA	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0021691999999999996	0.08138003308699353
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0021691999999999996	0.08138003308699353
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.08138003308699353
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0021691999999999996	0.08138003308699353
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.0021691999999999996	0.08138003308699353
MEIER-GORLIN SYNDROME 6; MGORS6	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0021691999999999996	0.08138003308699353
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.0021691999999999996	0.08138003308699353
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.08138003308699353
MEIER-GORLIN SYNDROME 3; MGORS3	0.0021691999999999996	0.08138003308699353
MEIER-GORLIN SYNDROME 5; MGORS5	0.0021691999999999996	0.08138003308699353
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0021691999999999996	0.08138003308699353
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0021691999999999996	0.08138003308699353
CRISS-CROSS HEART	0.0021691999999999996	0.08138003308699353
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0021691999999999996	0.08138003308699353
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.0021691999999999996	0.08138003308699353
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.0021691999999999996	0.08138003308699353
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0021691999999999996	0.08138003308699353
19Q13.11 MICRODELETION SYNDROME	0.0021691999999999996	0.08138003308699353
DOUBLE OUTLET RIGHT VENTRICLE	0.0021691999999999996	0.08138003308699353
NEMALINE MYOPATHY 2; NEM2	0.0021691999999999996	0.08138003308699353
LOCKED-IN SYNDROME	0.0021691999999999996	0.08138003308699353
MEIER-GORLIN SYNDROME 2; MGORS2	0.0021691999999999996	0.08138003308699353
PRIMARY DYSTONIA, DYT2 TYPE	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0021691999999999996	0.08138003308699353
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.0021691999999999996	0.08138003308699353
NATIVE AMERICAN MYOPATHY	0.0021691999999999996	0.08138003308699353
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.08138003308699353
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.0021691999999999996	0.08138003308699353
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.0021691999999999996	0.08138003308699353
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0021691999999999996	0.08138003308699353
ADENOCARCINOMA OF OVARY	0.0021691999999999996	0.08138003308699353
ATRESIA OF SMALL INTESTINE	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.0021691999999999996	0.08138003308699353
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.0021691999999999996	0.08138003308699353
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.0021691999999999996	0.08138003308699353
INFANTILE SYSTEMIC HYALINOSIS	0.0021691999999999996	0.08138003308699353
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0021691999999999996	0.08138003308699353
BARDET-BIEDL SYNDROME 1; BBS1	0.0020226539999999996	0.07588219133484225
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 35; JBTS35	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 33; JBTS33	0.0020226539999999996	0.07588219133484225
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 32; JBTS32	0.0020226539999999996	0.07588219133484225
MECKEL SYNDROME 13; MKS13	0.0020226539999999996	0.07588219133484225
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0020226539999999996	0.07588219133484225
USHER SYNDROME TYPE 1	0.0020226539999999996	0.07588219133484225
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0020226539999999996	0.07588219133484225
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 6	0.0020226539999999996	0.07588219133484225
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.0020226539999999996	0.07588219133484225
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.0020226539999999996	0.07588219133484225
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.0020226539999999996	0.07588219133484225
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0020226539999999996	0.07588219133484225
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.0020226539999999996	0.07588219133484225
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 25	0.0020226539999999996	0.07588219133484225
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.0020226539999999996	0.07588219133484225
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0020226539999999996	0.07588219133484225
WAARDENBURG-SHAH SYNDROME	0.0020226539999999996	0.07588219133484225
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0020226539999999996	0.07588219133484225
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.0020226539999999996	0.07588219133484225
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0020226539999999996	0.07588219133484225
IMMUNODEFICIENCY 23; IMD23	0.0020226539999999996	0.07588219133484225
OXOGLUTARIC ACIDURIA	0.0020226539999999996	0.07588219133484225
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.0020226539999999996	0.07588219133484225
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0020226539999999996	0.07588219133484225
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 2	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 21	0.0020226539999999996	0.07588219133484225
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.0020226539999999996	0.07588219133484225
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.0020226539999999996	0.07588219133484225
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.0020226539999999996	0.07588219133484225
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0020226539999999996	0.07588219133484225
PELLAGRA-LIKE SYNDROME	0.0020226539999999996	0.07588219133484225
NAVAJO NEUROHEPATOPATHY	0.0020226539999999996	0.07588219133484225
SENIOR-LOKEN SYNDROME	0.0020226539999999996	0.07588219133484225
PEROXISOME BIOGENESIS DISORDER 6B	0.0020226539999999996	0.07588219133484225
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0020226539999999996	0.07588219133484225
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 15	0.0020226539999999996	0.07588219133484225
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.0020226539999999996	0.07588219133484225
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.0020226539999999996	0.07588219133484225
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0020226539999999996	0.07588219133484225
HOYERAAL-HREIDARSSON SYNDROME	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 17; JBTS17	0.0020226539999999996	0.07588219133484225
ARIMA SYNDROME	0.0020226539999999996	0.07588219133484225
RICHARDS-RUNDLE SYNDROME; RRNS	0.0020226539999999996	0.07588219133484225
YOU-HOOVER-FONG SYNDROME; YHFS	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 8	0.0020226539999999996	0.07588219133484225
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0020226539999999996	0.07588219133484225
MARINESCO-SJÃ–GREN SYNDROME	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 28	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 27	0.0020226539999999996	0.07588219133484225
MARINESCO-SJOGREN SYNDROME; MSS	0.0020226539999999996	0.07588219133484225
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0020226539999999996	0.07588219133484225
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.0020226539999999996	0.07588219133484225
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.0020226539999999996	0.07588219133484225
JOUBERT SYNDROME 7	0.0020226539999999996	0.07588219133484225
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0020226539999999996	0.07588219133484225
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.0020226539999999996	0.07588219133484225
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.0020226539999999996	0.07588219133484225
DYSEQUILIBRIUM SYNDROME	0.002018519	0.07572706205362581
FAMILIAL DYSAUTONOMIA	0.002018519	0.07572706205362581
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.002018519	0.07572706205362581
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.002018519	0.07572706205362581
SPONTANEOUS PERIODIC HYPOTHERMIA	0.002018519	0.07572706205362581
COG8-CDG	0.002018519	0.07572706205362581
TYROSINEMIA TYPE 2	0.002018519	0.07572706205362581
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.002018519	0.07572706205362581
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.002018519	0.07572706205362581
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.002018519	0.07572706205362581
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.002018519	0.07572706205362581
FLYNN-AIRD SYNDROME	0.002018519	0.07572706205362581
EPISODIC ATAXIA TYPE 6	0.002018519	0.07572706205362581
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.002018519	0.07572706205362581
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.002018519	0.07572706205362581
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.002018519	0.07572706205362581
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.002018519	0.07572706205362581
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.002018519	0.07572706205362581
XERODERMA PIGMENTOSUM	0.002018519	0.07572706205362581
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.002018519	0.07572706205362581
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.002018519	0.07572706205362581
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.002018519	0.07572706205362581
CAMOS SYNDROME	0.002018519	0.07572706205362581
KALLMANN SYNDROME	0.002018519	0.07572706205362581
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.002018519	0.07572706205362581
ATAXIA-TELANGIECTASIA	0.002018519	0.07572706205362581
SIALIDOSIS TYPE 1	0.002018519	0.07572706205362581
LEIGH SYNDROME	0.002018519	0.07572706205362581
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.002018519	0.07572706205362581
ETHYLMALONIC ENCEPHALOPATHY	0.002018519	0.07572706205362581
SANDHOFF DISEASE	0.002018519	0.07572706205362581
METACHROMATIC LEUKODYSTROPHY	0.002018519	0.07572706205362581
MUCOPOLYSACCHARIDOSIS TYPE 3	0.002018519	0.07572706205362581
CONGENITAL MYASTHENIC SYNDROME	0.002018519	0.07572706205362581
NEUROFIBROMATOSIS TYPE 1	0.002018519	0.07572706205362581
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.002018519	0.07572706205362581
LHERMITTE-DUCLOS DISEASE	0.002018519	0.07572706205362581
DILATED CARDIOMYOPATHY WITH ATAXIA	0.002018519	0.07572706205362581
ANGELMAN SYNDROME	0.002018519	0.07572706205362581
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.002018519	0.07572706205362581
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.002018519	0.07572706205362581
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.002018519	0.07572706205362581
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.002018519	0.07572706205362581
PGM3-CDG	0.002018519	0.07572706205362581
RETT SYNDROME	0.002018519	0.07572706205362581
EARLY-ONSET LAFORA BODY DISEASE	0.002018519	0.07572706205362581
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.002018519	0.07572706205362581
WHIPPLE DISEASE	0.002018519	0.07572706205362581
GM1 GANGLIOSIDOSIS	0.002018519	0.07572706205362581
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.002018519	0.07572706205362581
TRIPLE A SYNDROME	0.002018519	0.07572706205362581
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.002018519	0.07572706205362581
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.002018519	0.07572706205362581
ISOLATED CEREBELLAR AGENESIS	0.002018519	0.07572706205362581
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.002018519	0.07572706205362581
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.002018519	0.07572706205362581
BETA-KETOTHIOLASE DEFICIENCY	0.002018519	0.07572706205362581
SYMMETRICAL THALAMIC CALCIFICATIONS	0.002018519	0.07572706205362581
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.002018519	0.07572706205362581
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.002018519	0.07572706205362581
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.002018519	0.07572706205362581
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.002018519	0.07572706205362581
BEHÃ‡ET DISEASE	0.002018519	0.07572706205362581
HEREDITARY HYPEREKPLEXIA	0.002018519	0.07572706205362581
ATYPICAL TERATOID RHABDOID TUMOR	0.002018519	0.07572706205362581
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.002018519	0.07572706205362581
KUFOR-RAKEB SYNDROME	0.002018519	0.07572706205362581
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.002018519	0.07572706205362581
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.002018519	0.07572706205362581
LISSENCEPHALY 3; LIS3	0.002018519	0.07572706205362581
DIAMINOPENTANURIA	0.002018519	0.07572706205362581
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.002018519	0.07572706205362581
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.002018519	0.07572706205362581
METACHROMATIC LEUKODYSTROPHY	0.002018519	0.07572706205362581
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.002018519	0.07572706205362581
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.002018519	0.07572706205362581
MEGALENCEPHALY WITH DYSMYELINATION	0.002018519	0.07572706205362581
GLUTATHIONE SYNTHETASE DEFICIENCY	0.002018519	0.07572706205362581
MAPLE SYRUP URINE DISEASE; MSUD	0.002018519	0.07572706205362581
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.002018519	0.07572706205362581
FLYNN-AIRD SYNDROME	0.002018519	0.07572706205362581
ALEXANDER DISEASE	0.002018519	0.07572706205362581
KNOBLOCH SYNDROME 1; KNO1	0.002018519	0.07572706205362581
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.002018519	0.07572706205362581
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.002018519	0.07572706205362581
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.002018519	0.07572706205362581
KEARNS-SAYRE SYNDROME; KSS	0.002018519	0.07572706205362581
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.002018519	0.07572706205362581
CYCLIC VOMITING SYNDROME	0.002018519	0.07572706205362581
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.002018519	0.07572706205362581
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.002018519	0.07572706205362581
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.002018519	0.07572706205362581
THYROCEREBRORETINAL SYNDROME	0.002018519	0.07572706205362581
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002018519	0.07572706205362581
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.002018519	0.07572706205362581
COCKAYNE SYNDROME A; CSA	0.002018519	0.07572706205362581
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.002018519	0.07572706205362581
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.002018519	0.07572706205362581
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.002018519	0.07572706205362581
NEUROFIBROMATOSIS, TYPE II	0.002018519	0.07572706205362581
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.002018519	0.07572706205362581
BANGSTAD SYNDROME	0.002018519	0.07572706205362581
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.002018519	0.07572706205362581
PELIZAEUS-MERZBACHER DISEASE	0.002018519	0.07572706205362581
CEREBELLOPARENCHYMAL DISORDER II	0.002018519	0.07572706205362581
PERRAULT SYNDROME 5; PRLTS5	0.002018519	0.07572706205362581
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.002018519	0.07572706205362581
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.002018519	0.07572706205362581
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00163132	0.061200846199278215
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00163132	0.061200846199278215
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00163132	0.061200846199278215
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00163132	0.061200846199278215
CRANIOFACIAL DYSSYNOSTOSIS	0.00163132	0.061200846199278215
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00163132	0.061200846199278215
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00163132	0.061200846199278215
CEREBROOCULONASAL SYNDROME	0.00163132	0.061200846199278215
PTERYGIUM COLLI, ISOLATED	0.00163132	0.061200846199278215
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00163132	0.061200846199278215
CRANIOECTODERMAL DYSPLASIA	0.00163132	0.061200846199278215
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00163132	0.061200846199278215
PENOSCROTAL TRANSPOSITION	0.00163132	0.061200846199278215
8Q21.11 MICRODELETION SYNDROME	0.00163132	0.061200846199278215
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00163132	0.061200846199278215
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00163132	0.061200846199278215
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00163132	0.061200846199278215
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00163132	0.061200846199278215
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00163132	0.061200846199278215
MONOSOMY 13Q14	0.00163132	0.061200846199278215
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00163132	0.061200846199278215
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00163132	0.061200846199278215
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00163132	0.061200846199278215
COFFIN-SIRIS SYNDROME 10; CSS10	0.00163132	0.061200846199278215
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00163132	0.061200846199278215
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00163132	0.061200846199278215
NOONAN SYNDROME 4; NS4	0.00163132	0.061200846199278215
FEINGOLD SYNDROME 1; FGLDS1	0.00163132	0.061200846199278215
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00163132	0.061200846199278215
PHAVER SYNDROME	0.00163132	0.061200846199278215
ACHALASIA-MICROCEPHALY SYNDROME	0.00163132	0.061200846199278215
OROFACIAL CLEFT 15	0.00163132	0.061200846199278215
ABRUZZO-ERICKSON SYNDROME	0.00163132	0.061200846199278215
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.061200846199278215
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00163132	0.061200846199278215
CLASSICAL EHLERS-DANLOS SYNDROME	0.00163132	0.061200846199278215
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.061200846199278215
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00163132	0.061200846199278215
KEIPERT SYNDROME	0.00163132	0.061200846199278215
NOONAN SYNDROME 8; NS8	0.00163132	0.061200846199278215
DEAFNESS-HYPOGONADISM SYNDROME	0.00163132	0.061200846199278215
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00163132	0.061200846199278215
MILROY DISEASE	0.00163132	0.061200846199278215
FETAL VALPROATE SYNDROME	0.00163132	0.061200846199278215
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00163132	0.061200846199278215
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00163132	0.061200846199278215
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00163132	0.061200846199278215
TURNER SYNDROME	0.00163132	0.061200846199278215
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00163132	0.061200846199278215
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00163132	0.061200846199278215
RING CHROMOSOME 8 SYNDROME	0.00163132	0.061200846199278215
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.00163132	0.061200846199278215
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00163132	0.061200846199278215
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00163132	0.061200846199278215
CAREY-FINEMAN-ZITER SYNDROME	0.00163132	0.061200846199278215
TRISOMY XQ28	0.00163132	0.061200846199278215
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00163132	0.061200846199278215
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00163132	0.061200846199278215
CARTILAGE-HAIR HYPOPLASIA	0.00163132	0.061200846199278215
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00163132	0.061200846199278215
DUBOWITZ SYNDROME	0.00163132	0.061200846199278215
RING CHROMOSOME 7 SYNDROME	0.00163132	0.061200846199278215
RING CHROMOSOME 6 SYNDROME	0.00163132	0.061200846199278215
GORLIN SYNDROME	0.00163132	0.061200846199278215
SCHOLTE SYNDROME; SHLTS	0.00163132	0.061200846199278215
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00163132	0.061200846199278215
CEREBROFACIOTHORACIC DYSPLASIA	0.00163132	0.061200846199278215
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00163132	0.061200846199278215
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00163132	0.061200846199278215
LEGIUS SYNDROME	0.00163132	0.061200846199278215
FRONTORHINY	0.00163132	0.061200846199278215
CRANIOECTODERMAL DYSPLASIA 1	0.00163132	0.061200846199278215
TRISOMY 20P	0.00163132	0.061200846199278215
ACRORENAL-MANDIBULAR SYNDROME	0.00163132	0.061200846199278215
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.061200846199278215
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00163132	0.061200846199278215
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00163132	0.061200846199278215
49,XXXYY SYNDROME	0.00163132	0.061200846199278215
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00163132	0.061200846199278215
DOWN SYNDROME	0.00163132	0.061200846199278215
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00163132	0.061200846199278215
RENAL AGENESIS, BILATERAL	0.00163132	0.061200846199278215
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00163132	0.061200846199278215
MARTSOLF SYNDROME	0.00163132	0.061200846199278215
BALLER-GEROLD SYNDROME	0.00163132	0.061200846199278215
STICKLER SYNDROME	0.00163132	0.061200846199278215
MONOSOMY 5P	0.00163132	0.061200846199278215
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00163132	0.061200846199278215
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00163132	0.061200846199278215
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00163132	0.061200846199278215
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00163132	0.061200846199278215
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00163132	0.061200846199278215
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00163132	0.061200846199278215
3Q13 MICRODELETION SYNDROME	0.00163132	0.061200846199278215
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00163132	0.061200846199278215
HYPOTONIA-CYSTINURIA SYNDROME	0.00163132	0.061200846199278215
14Q11.2 MICRODELETION SYNDROME	0.00163132	0.061200846199278215
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00163132	0.061200846199278215
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00163132	0.061200846199278215
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00163132	0.061200846199278215
BRITTLE CORNEA SYNDROME	0.00163132	0.061200846199278215
NEUROFACIODIGITORENAL SYNDROME	0.00163132	0.061200846199278215
9P13 MICRODELETION SYNDROME	0.00163132	0.061200846199278215
WHITE FORELOCK WITH MALFORMATIONS	0.00163132	0.061200846199278215
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.061200846199278215
EHLERS-DANLOS SYNDROME, TYPE I	0.00163132	0.061200846199278215
MEGAEPIPHYSEAL DWARFISM	0.00163132	0.061200846199278215
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00163132	0.061200846199278215
CEREBROOCULONASAL SYNDROME	0.00163132	0.061200846199278215
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00163132	0.061200846199278215
EPICANTHUS	0.00163132	0.061200846199278215
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00163132	0.061200846199278215
RING CHROMOSOME 13 SYNDROME	0.00163132	0.061200846199278215
URBAN-ROGERS-MEYER SYNDROME	0.00163132	0.061200846199278215
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.061200846199278215
ATELOSTEOGENESIS TYPE II	0.00163132	0.061200846199278215
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00163132	0.061200846199278215
VELO-FACIAL-SKELETAL SYNDROME	0.00163132	0.061200846199278215
MONOSOMY X	0.00163132	0.061200846199278215
MOSAIC MONOSOMY X	0.00163132	0.061200846199278215
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.061200846199278215
LICHTENSTEIN SYNDROME	0.00163132	0.061200846199278215
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00163132	0.061200846199278215
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00163132	0.061200846199278215
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00163132	0.061200846199278215
FRONTONASAL DYSPLASIA 1; FND1	0.00163132	0.061200846199278215
COSTELLO SYNDROME	0.00163132	0.061200846199278215
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00163132	0.061200846199278215
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00163132	0.061200846199278215
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00163132	0.061200846199278215
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00163132	0.061200846199278215
NASODIGITOACOUSTIC SYNDROME	0.00163132	0.061200846199278215
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00163132	0.061200846199278215
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00163132	0.061200846199278215
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00163132	0.061200846199278215
SCARF SYNDROME	0.00163132	0.061200846199278215
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00163132	0.061200846199278215
BRADDOCK SYNDROME	0.00163132	0.061200846199278215
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00163132	0.061200846199278215
DIAMOND-BLACKFAN ANEMIA 1	0.00163132	0.061200846199278215
16P12.1P12.3 TRIPLICATION SYNDROME	0.00163132	0.061200846199278215
600736 VELOFACIOSKELETAL SYNDROME	0.00163132	0.061200846199278215
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00163132	0.061200846199278215
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00163132	0.061200846199278215
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00163132	0.061200846199278215
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00163132	0.061200846199278215
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00163132	0.061200846199278215
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00163132	0.061200846199278215
CRI-DU-CHAT SYNDROME	0.00163132	0.061200846199278215
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.00163132	0.061200846199278215
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00163132	0.061200846199278215
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00163132	0.061200846199278215
PRIMARY PULMONARY HYPOPLASIA	0.00163132	0.061200846199278215
MONOSOMY 22	0.00163132	0.061200846199278215
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00163132	0.061200846199278215
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00163132	0.061200846199278215
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00163132	0.061200846199278215
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00163132	0.061200846199278215
MOEBIUS SYNDROME	0.00163132	0.061200846199278215
MYOTONIA PERMANENS	0.00163132	0.061200846199278215
ACRODYSOSTOSIS	0.00163132	0.061200846199278215
MUCOLIPIDOSIS TYPE II	0.00163132	0.061200846199278215
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00163132	0.061200846199278215
GMS SYNDROME	0.00163132	0.061200846199278215
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00163132	0.061200846199278215
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00163132	0.061200846199278215
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00163132	0.061200846199278215
PROGEROID SYNDROME, PETTY TYPE	0.00163132	0.061200846199278215
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00163132	0.061200846199278215
SCARF SYNDROME	0.00163132	0.061200846199278215
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00163132	0.061200846199278215
SUMMITT SYNDROME	0.00163132	0.061200846199278215
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00163132	0.061200846199278215
OMODYSPLASIA 1; OMOD1	0.00163132	0.061200846199278215
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.061200846199278215
JUBERG-MARSIDI SYNDROME	0.00163132	0.061200846199278215
OROFACIODIGITAL SYNDROME IV; OFD4	0.00163132	0.061200846199278215
6P22 MICRODELETION SYNDROME	0.00163132	0.061200846199278215
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00163132	0.061200846199278215
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00163132	0.061200846199278215
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00163132	0.061200846199278215
JACOBSEN SYNDROME	0.00163132	0.061200846199278215
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00163132	0.061200846199278215
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00163132	0.061200846199278215
DUANE-RADIAL RAY SYNDROME; DRRS	0.00163132	0.061200846199278215
ACRO-RENAL-OCULAR SYNDROME	0.00163132	0.061200846199278215
DISTAL TRISOMY 5Q	0.00163132	0.061200846199278215
SIFRIM-HITZ-WEISS SYNDROME	0.00163132	0.061200846199278215
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00163132	0.061200846199278215
SILLENCE SYNDROME	0.00163132	0.061200846199278215
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00163132	0.061200846199278215
ACROOTOOCULAR SYNDROME	0.00163132	0.061200846199278215
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00163132	0.061200846199278215
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.0014770999999999999	0.05541510551023333
EPISODIC ATAXIA TYPE 4	0.0014770999999999999	0.05541510551023333
ACERULOPLASMINEMIA	0.0014770999999999999	0.05541510551023333
EPISODIC ATAXIA, TYPE 8	0.0014770999999999999	0.05541510551023333
ALLAN-HERNDON-DUDLEY SYNDROME	0.0014770999999999999	0.05541510551023333
USHER SYNDROME TYPE 3	0.0014770999999999999	0.05541510551023333
NEUROPATHY, HEREDITARY SENSORY, ATYPICAL	0.0014770999999999999	0.05541510551023333
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.0014770999999999999	0.05541510551023333
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.0014770999999999999	0.05541510551023333
CEREBELLAR HYPOPLASIA	0.0014770999999999999	0.05541510551023333
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.0014770999999999999	0.05541510551023333
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.0014770999999999999	0.05541510551023333
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0014770999999999999	0.05541510551023333
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.0014770999999999999	0.05541510551023333
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.0014770999999999999	0.05541510551023333
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.0014770999999999999	0.05541510551023333
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.0014770999999999999	0.05541510551023333
BOUCHER-NEUHAUSER SYNDROME	0.0014770999999999999	0.05541510551023333
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0014770999999999999	0.05541510551023333
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.0014770999999999999	0.05541510551023333
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.0014770999999999999	0.05541510551023333
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.0014770999999999999	0.05541510551023333
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.05541510551023333
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0014770999999999999	0.05541510551023333
USHER SYNDROME TYPE 2	0.0014770999999999999	0.05541510551023333
RHOMBENCEPHALOSYNAPSIS	0.0014770999999999999	0.05541510551023333
CENTRAL NEUROCYTOMA	0.0014770999999999999	0.05541510551023333
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.0014770999999999999	0.05541510551023333
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0014770999999999999	0.05541510551023333
PENDRED SYNDROME	0.0014770999999999999	0.05541510551023333
WERNICKE-KORSAKOFF SYNDROME	0.0014770999999999999	0.05541510551023333
HEREDITARY SPASTIC PARAPLEGIA	0.0014770999999999999	0.05541510551023333
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.0014770999999999999	0.05541510551023333
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.0014770999999999999	0.05541510551023333
KURU, SUSCEPTIBILITY TO	0.0014770999999999999	0.05541510551023333
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0014770999999999999	0.05541510551023333
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.0014770999999999999	0.05541510551023333
TRYPTOPHANURIA WITH DWARFISM	0.0014770999999999999	0.05541510551023333
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.0014770999999999999	0.05541510551023333
KIKUCHI-FUJIMOTO DISEASE	0.0014770999999999999	0.05541510551023333
NEUROFIBROMATOSIS TYPE 2	0.0014770999999999999	0.05541510551023333
CHANARIN-DORFMAN SYNDROME	0.0014770999999999999	0.05541510551023333
MUCOLIPIDOSIS TYPE IV	0.0014770999999999999	0.05541510551023333
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.0014770999999999999	0.05541510551023333
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0014770999999999999	0.05541510551023333
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 30; SCA30	0.0014770999999999999	0.05541510551023333
ADULT POLYGLUCOSAN BODY DISEASE	0.0014770999999999999	0.05541510551023333
ALLAN-HERNDON-DUDLEY SYNDROME	0.0014770999999999999	0.05541510551023333
272600 TAPETORETINAL DEGENERATION WITH ATAXIA	0.0014770999999999999	0.05541510551023333
245800 LAURENCE-MOON SYNDROME	0.0014770999999999999	0.05541510551023333
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 37; SCA37	0.0014770999999999999	0.05541510551023333
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.0014770999999999999	0.05541510551023333
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.0014770999999999999	0.05541510551023333
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0014770999999999999	0.05541510551023333
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.0014770999999999999	0.05541510551023333
KEARNS-SAYRE SYNDROME	0.0014770999999999999	0.05541510551023333
POLYMYOCLONUS, INFANTILE	0.0014770999999999999	0.05541510551023333
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.0014770999999999999	0.05541510551023333
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 32; SCA32	0.0014770999999999999	0.05541510551023333
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.0014770999999999999	0.05541510551023333
GEMIGNANI SYNDROME	0.0014770999999999999	0.05541510551023333
REFSUM DISEASE	0.0014770999999999999	0.05541510551023333
MUSCULAR ATROPHY-ATAXIA-RETINITIS PIGMENTOSA-DIABETES MELLITUS SYNDROME	0.0014770999999999999	0.05541510551023333
DE SANCTIS-CACCHIONE SYNDROME	0.0014770999999999999	0.05541510551023333
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.0014770999999999999	0.05541510551023333
POSTERIOR CORTICAL ATROPHY	0.0014770999999999999	0.05541510551023333
LEGIONELLOSIS	0.0014770999999999999	0.05541510551023333
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.0014770999999999999	0.05541510551023333
SANDHOFF DISEASE	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.0014770999999999999	0.05541510551023333
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.0014770999999999999	0.05541510551023333
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05541510551023333
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.0014770999999999999	0.05541510551023333
ARGININOSUCCINIC ACIDURIA	0.0014770999999999999	0.05541510551023333
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.0014770999999999999	0.05541510551023333
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.0014770999999999999	0.05541510551023333
HYPOMYELINATION-HYPOGONADOTROPIC HYPOGONADISM-HYPODONTIA SYNDROME	0.0014770999999999999	0.05541510551023333
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0014770999999999999	0.05541510551023333
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.0014770999999999999	0.05541510551023333
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.0014770999999999999	0.05541510551023333
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.0014770999999999999	0.05541510551023333
ATAXIA-HYPOGONADISM-CHOROIDAL DYSTROPHY SYNDROME	0.0014770999999999999	0.05541510551023333
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0014770999999999999	0.05541510551023333
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.0014770999999999999	0.05541510551023333
USHER SYNDROME	0.0014770999999999999	0.05541510551023333
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.0014770999999999999	0.05541510551023333
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.0014770999999999999	0.05541510551023333
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.0014770999999999999	0.05541510551023333
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.0014770999999999999	0.05541510551023333
PITUITARY CARCINOMA	0.0014770999999999999	0.05541510551023333
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0014770999999999999	0.05541510551023333
AGEL AMYLOIDOSIS	0.0014770999999999999	0.05541510551023333
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.0014770999999999999	0.05541510551023333
FAMILIAL PAROXYSMAL ATAXIA	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA, X-LINKED 2	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.0014770999999999999	0.05541510551023333
ATAXIA-PANCYTOPENIA SYNDROME	0.0014770999999999999	0.05541510551023333
WALDENSTRÃ–M MACROGLOBULINEMIA	0.0014770999999999999	0.05541510551023333
CAMURATI-ENGELMANN DISEASE	0.0014770999999999999	0.05541510551023333
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.0014770999999999999	0.05541510551023333
HODGKIN LYMPHOMA	0.0014770999999999999	0.05541510551023333
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA TYPE 17	0.0014770999999999999	0.05541510551023333
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.0014770999999999999	0.05541510551023333
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA TYPE 4	0.0014770999999999999	0.05541510551023333
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.0014770999999999999	0.05541510551023333
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0014770999999999999	0.05541510551023333
NYSTAGMUS, HEREDITARY VERTICAL	0.0014770999999999999	0.05541510551023333
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.0014770999999999999	0.05541510551023333
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0014770999999999999	0.05541510551023333
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.0014770999999999999	0.05541510551023333
PIEBALDISM	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0014770999999999999	0.05541510551023333
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05541510551023333
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.0014770999999999999	0.05541510551023333
OPTIC ATROPHY 1; OPA1	0.0014770999999999999	0.05541510551023333
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.0014770999999999999	0.05541510551023333
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0014770999999999999	0.05541510551023333
POSTERIOR COLUMN ATAXIA	0.0014770999999999999	0.05541510551023333
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.0014770999999999999	0.05541510551023333
VON HIPPEL-LINDAU DISEASE	0.0014770999999999999	0.05541510551023333
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.0014770999999999999	0.05541510551023333
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0014770999999999999	0.05541510551023333
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.0014770999999999999	0.05541510551023333
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0014770999999999999	0.05541510551023333
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.0014770999999999999	0.05541510551023333
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.0014770999999999999	0.05541510551023333
LEBER HEREDITARY OPTIC NEUROPATHY	0.0014770999999999999	0.05541510551023333
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0014770999999999999	0.05541510551023333
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.0014770999999999999	0.05541510551023333
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.0014770999999999999	0.05541510551023333
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.0014770999999999999	0.05541510551023333
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.0014770999999999999	0.05541510551023333
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.0014770999999999999	0.05541510551023333
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.05541510551023333
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0014770999999999999	0.05541510551023333
RICHARDS-RUNDLE SYNDROME	0.0014770999999999999	0.05541510551023333
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.0014770999999999999	0.05541510551023333
CHAND SYNDROME	0.0014770999999999999	0.05541510551023333
MACHADO-JOSEPH DISEASE; MJD	0.0014770999999999999	0.05541510551023333
ATAXIA WITH FASCICULATIONS	0.0014770999999999999	0.05541510551023333
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0014770999999999999	0.05541510551023333
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.0014770999999999999	0.05541510551023333
JOUBERT SYNDROME 5	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPLEGIA TYPE 2	0.0014770999999999999	0.05541510551023333
GILLESPIE SYNDROME; GLSP	0.0014770999999999999	0.05541510551023333
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.0014770999999999999	0.05541510551023333
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.0014770999999999999	0.05541510551023333
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0014770999999999999	0.05541510551023333
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.05541510551023333
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.0014770999999999999	0.05541510551023333
HEREDITARY SPHEROCYTOSIS	0.0014770999999999999	0.05541510551023333
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.0014770999999999999	0.05541510551023333
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0014770999999999999	0.05541510551023333
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0014770999999999999	0.05541510551023333
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.0014770999999999999	0.05541510551023333
RAVINE SYNDROME	0.0014770999999999999	0.05541510551023333
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.0014770999999999999	0.05541510551023333
GÃ“MEZ-LÃ“PEZ-HERNÃNDEZ SYNDROME	0.0014770999999999999	0.05541510551023333
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.0014770999999999999	0.05541510551023333
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0014770999999999999	0.05541510551023333
STIMMLER SYNDROME	0.0014770999999999999	0.05541510551023333
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.05541510551023333
ERDHEIM-CHESTER DISEASE	0.0014770999999999999	0.05541510551023333
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.0014770999999999999	0.05541510551023333
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 31	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 41; SCA41	0.0014770999999999999	0.05541510551023333
ACERULOPLASMINEMIA	0.0014770999999999999	0.05541510551023333
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.0014770999999999999	0.05541510551023333
DEMENTIA, FAMILIAL DANISH	0.0014770999999999999	0.05541510551023333
JOUBERT SYNDROME 4	0.0014770999999999999	0.05541510551023333
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.0014770999999999999	0.05541510551023333
CLASSIC HODGKIN LYMPHOMA	0.0014770999999999999	0.05541510551023333
MICRO SYNDROME	0.001086973	0.040779042368001395
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001086973	0.040779042368001395
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.040779042368001395
WAISMAN SYNDROME; WSMN	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.040779042368001395
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.040779042368001395
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001086973	0.040779042368001395
FUCOSIDOSIS	0.001086973	0.040779042368001395
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.040779042368001395
3Q29 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
LISSENCEPHALY 4	0.001086973	0.040779042368001395
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.040779042368001395
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.040779042368001395
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.040779042368001395
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.040779042368001395
CODAS SYNDROME	0.001086973	0.040779042368001395
RUVALCABA SYNDROME	0.001086973	0.040779042368001395
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.040779042368001395
1Q21.1 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.040779042368001395
BAND HETEROTOPIA; BH	0.001086973	0.040779042368001395
INCONTINENTIA PIGMENTI	0.001086973	0.040779042368001395
PETERS-PLUS SYNDROME; PTRPLS	0.001086973	0.040779042368001395
MUENKE SYNDROME	0.001086973	0.040779042368001395
FILIPPI SYNDROME	0.001086973	0.040779042368001395
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001086973	0.040779042368001395
TIMOTHY SYNDROME; TS	0.001086973	0.040779042368001395
PHACE ASSOCIATION	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.040779042368001395
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.001086973	0.040779042368001395
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.040779042368001395
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.040779042368001395
DUANE RETRACTION SYNDROME	0.001086973	0.040779042368001395
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.040779042368001395
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.001086973	0.040779042368001395
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.040779042368001395
WILSON-TURNER SYNDROME	0.001086973	0.040779042368001395
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
SEVERE CANAVAN DISEASE	0.001086973	0.040779042368001395
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001086973	0.040779042368001395
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001086973	0.040779042368001395
ISOVALERIC ACIDEMIA	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.040779042368001395
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001086973	0.040779042368001395
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.040779042368001395
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.001086973	0.040779042368001395
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001086973	0.040779042368001395
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.040779042368001395
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001086973	0.040779042368001395
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.040779042368001395
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.040779042368001395
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.040779042368001395
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.040779042368001395
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001086973	0.040779042368001395
L1 SYNDROME	0.001086973	0.040779042368001395
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.040779042368001395
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001086973	0.040779042368001395
CHROMOSOME 16P13.3 DELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.040779042368001395
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 90	0.001086973	0.040779042368001395
CORNELIA DE LANGE SYNDROME 3	0.001086973	0.040779042368001395
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.001086973	0.040779042368001395
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.040779042368001395
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 7	0.001086973	0.040779042368001395
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.001086973	0.040779042368001395
POTOCKI-LUPSKI SYNDROME	0.001086973	0.040779042368001395
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.040779042368001395
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.001086973	0.040779042368001395
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001086973	0.040779042368001395
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001086973	0.040779042368001395
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.040779042368001395
SHUKLA-VERNON SYNDROME; SHUVER	0.001086973	0.040779042368001395
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.040779042368001395
PETTIGREW SYNDROME	0.001086973	0.040779042368001395
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.040779042368001395
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.040779042368001395
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.001086973	0.040779042368001395
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.040779042368001395
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.040779042368001395
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001086973	0.040779042368001395
TARP SYNDROME	0.001086973	0.040779042368001395
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001086973	0.040779042368001395
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.040779042368001395
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.040779042368001395
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.040779042368001395
PHACE SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.040779042368001395
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.040779042368001395
15Q14 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.040779042368001395
SCHINDLER DISEASE, TYPE I	0.001086973	0.040779042368001395
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.040779042368001395
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.040779042368001395
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001086973	0.040779042368001395
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.040779042368001395
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.040779042368001395
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.040779042368001395
GLASS SYNDROME	0.001086973	0.040779042368001395
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.040779042368001395
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001086973	0.040779042368001395
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.040779042368001395
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001086973	0.040779042368001395
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.040779042368001395
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001086973	0.040779042368001395
SOTOS SYNDROME	0.001086973	0.040779042368001395
MOSAIC TRISOMY 14	0.001086973	0.040779042368001395
RECOMBINANT 8 SYNDROME	0.001086973	0.040779042368001395
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.040779042368001395
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
CLASSIC PHENYLKETONURIA	0.001086973	0.040779042368001395
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001086973	0.040779042368001395
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.040779042368001395
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001086973	0.040779042368001395
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.040779042368001395
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.040779042368001395
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.040779042368001395
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.040779042368001395
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.040779042368001395
2P21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
ALG3-CDG	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.040779042368001395
DIGEORGE SYNDROME; DGS	0.001086973	0.040779042368001395
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001086973	0.040779042368001395
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.040779042368001395
HARTNUP DISORDER	0.001086973	0.040779042368001395
DPAGT1-CDG	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.001086973	0.040779042368001395
CONGENITAL TOXOPLASMOSIS	0.001086973	0.040779042368001395
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.040779042368001395
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.040779042368001395
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.040779042368001395
6Q TERMINAL DELETION SYNDROME	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.040779042368001395
WEBB-DATTANI SYNDROME; WEDAS	0.001086973	0.040779042368001395
ALG1-CDG	0.001086973	0.040779042368001395
DISTAL MONOSOMY 15Q	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.040779042368001395
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.040779042368001395
KABUKI SYNDROME 1	0.001086973	0.040779042368001395
XQ21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.040779042368001395
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001086973	0.040779042368001395
KBG SYNDROME	0.001086973	0.040779042368001395
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001086973	0.040779042368001395
CANAVAN DISEASE	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001086973	0.040779042368001395
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.040779042368001395
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001086973	0.040779042368001395
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.040779042368001395
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.040779042368001395
MIRAGE SYNDROME; MIRAGE	0.001086973	0.040779042368001395
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.040779042368001395
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.040779042368001395
KEUTEL SYNDROME	0.001086973	0.040779042368001395
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.040779042368001395
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.040779042368001395
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.040779042368001395
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001086973	0.040779042368001395
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.040779042368001395
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001086973	0.040779042368001395
COFFIN-SIRIS SYNDROME 1; CSS1	0.001086973	0.040779042368001395
CATEL-MANZKE SYNDROME; CATMANS	0.001086973	0.040779042368001395
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.040779042368001395
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.040779042368001395
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.040779042368001395
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.040779042368001395
SCHIZENCEPHALY	0.001086973	0.040779042368001395
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.040779042368001395
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.040779042368001395
DISTAL MONOSOMY 19P13.3	0.001086973	0.040779042368001395
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.040779042368001395
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.040779042368001395
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.040779042368001395
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.040779042368001395
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.040779042368001395
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.040779042368001395
VICI SYNDROME	0.001086973	0.040779042368001395
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.040779042368001395
PALLISTER-HALL SYNDROME	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.040779042368001395
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.040779042368001395
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001086973	0.040779042368001395
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001086973	0.040779042368001395
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001086973	0.040779042368001395
HYDRANENCEPHALY	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.040779042368001395
ADENYLOSUCCINASE DEFICIENCY	0.001086973	0.040779042368001395
COHEN SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001086973	0.040779042368001395
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.040779042368001395
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.040779042368001395
KLEEFSTRA SYNDROME 2; KLEFS2	0.001086973	0.040779042368001395
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.040779042368001395
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.040779042368001395
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
MACDERMOT-WINTER SYNDROME	0.001086973	0.040779042368001395
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.040779042368001395
WYBURN-MASON SYNDROME	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.001086973	0.040779042368001395
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.001086973	0.040779042368001395
ADAMS-OLIVER SYNDROME 1; AOS1	0.001086973	0.040779042368001395
2Q37 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.040779042368001395
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.040779042368001395
PFEIFFER SYNDROME TYPE 2	0.001086973	0.040779042368001395
JABERI-ELAHI SYNDROME; JABELS	0.001086973	0.040779042368001395
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.040779042368001395
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001086973	0.040779042368001395
16P13.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
PRADER-WILLI SYNDROME; PWS	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.040779042368001395
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.001086973	0.040779042368001395
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.001086973	0.040779042368001395
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.040779042368001395
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.040779042368001395
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.040779042368001395
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.040779042368001395
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.001086973	0.040779042368001395
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001086973	0.040779042368001395
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.040779042368001395
CRANIOPHARYNGIOMA	0.001086973	0.040779042368001395
DONNAI-BARROW SYNDROME	0.001086973	0.040779042368001395
HERNÃNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.040779042368001395
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.040779042368001395
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001086973	0.040779042368001395
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.040779042368001395
NETHERTON SYNDROME	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.040779042368001395
VICI SYNDROME; VICIS	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.040779042368001395
NARP SYNDROME	0.001086973	0.040779042368001395
LEBER CONGENITAL AMAUROSIS	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.040779042368001395
CHROMOSOME 16P13.2 DELETION SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.040779042368001395
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.040779042368001395
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.040779042368001395
ARGININEMIA	0.001086973	0.040779042368001395
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001086973	0.040779042368001395
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.040779042368001395
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.040779042368001395
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.040779042368001395
WALKER-WARBURG SYNDROME	0.001086973	0.040779042368001395
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.040779042368001395
LANDAU-KLEFFNER SYNDROME	0.001086973	0.040779042368001395
OPTIC PATHWAY GLIOMA	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001086973	0.040779042368001395
MUCOPOLYSACCHARIDOSIS TYPE 2	0.001086973	0.040779042368001395
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001086973	0.040779042368001395
MULTIPLE SULFATASE DEFICIENCY	0.001086973	0.040779042368001395
KETOADIPICACIDURIA	0.001086973	0.040779042368001395
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001086973	0.040779042368001395
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.040779042368001395
GALLOWAY-MOWAT SYNDROME	0.001086973	0.040779042368001395
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.040779042368001395
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.040779042368001395
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.020467085824608922
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.020467085824608922
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.020467085824608922
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020467085824608922
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.020467085824608922
TARP SYNDROME; TARPS	0.000545554	0.020467085824608922
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.020467085824608922
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020467085824608922
OROTIC ACIDURIA	0.000545554	0.020467085824608922
EPIDERMAL NEVUS SYNDROME	0.000545554	0.020467085824608922
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.020467085824608922
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.020467085824608922
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.020467085824608922
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608922
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.020467085824608922
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.020467085824608922
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.020467085824608922
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.020467085824608922
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.020467085824608922
ABETAL34V AMYLOIDOSIS	0.000545554	0.020467085824608922
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.020467085824608922
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.020467085824608922
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.020467085824608922
MOSAIC TRISOMY 9	0.000545554	0.020467085824608922
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020467085824608922
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.020467085824608922
8P23.1 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
12Q14 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
3Q29 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
CURRY-JONES SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.020467085824608922
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.020467085824608922
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.020467085824608922
RIGID SPINE SYNDROME	0.000545554	0.020467085824608922
ZEBRA BODY MYOPATHY	0.000545554	0.020467085824608922
ISOLATED PLAGIOCEPHALY	0.000545554	0.020467085824608922
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.020467085824608922
YUNIS-VARON SYNDROME	0.000545554	0.020467085824608922
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.020467085824608922
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.020467085824608922
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.020467085824608922
WEAVER SYNDROME	0.000545554	0.020467085824608922
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.020467085824608922
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.020467085824608922
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.020467085824608922
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.020467085824608922
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.020467085824608922
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.020467085824608922
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.020467085824608922
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000545554	0.020467085824608922
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.020467085824608922
FARBER DISEASE	0.000545554	0.020467085824608922
LOWRY-MACLEAN SYNDROME	0.000545554	0.020467085824608922
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.020467085824608922
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.020467085824608922
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.020467085824608922
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.020467085824608922
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.020467085824608922
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020467085824608922
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.020467085824608922
ALPHA-MANNOSIDOSIS	0.000545554	0.020467085824608922
MEDULLOBLASTOMA	0.000545554	0.020467085824608922
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.020467085824608922
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.020467085824608922
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.020467085824608922
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020467085824608922
3C SYNDROME	0.000545554	0.020467085824608922
CHAR SYNDROME	0.000545554	0.020467085824608922
HYDROXYKYNURENINURIA	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.020467085824608922
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.020467085824608922
PETERS PLUS SYNDROME	0.000545554	0.020467085824608922
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.000545554	0.020467085824608922
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.020467085824608922
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.020467085824608922
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.020467085824608922
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020467085824608922
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.020467085824608922
ATELOSTEOGENESIS TYPE III	0.000545554	0.020467085824608922
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.020467085824608922
RABSON-MENDENHALL SYNDROME	0.000545554	0.020467085824608922
JAWAD SYNDROME	0.000545554	0.020467085824608922
RAINE SYNDROME	0.000545554	0.020467085824608922
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.020467085824608922
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.020467085824608922
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.020467085824608922
TRANSKETOLASE DEFICIENCY	0.000545554	0.020467085824608922
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020467085824608922
NETHERTON SYNDROME; NETH	0.000545554	0.020467085824608922
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.020467085824608922
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.020467085824608922
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.020467085824608922
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.020467085824608922
MUCOLIPIDOSIS IV; ML4	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.020467085824608922
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.020467085824608922
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.020467085824608922
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.020467085824608922
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.020467085824608922
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.020467085824608922
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.020467085824608922
PEDIATRIC-ONSET GRAVES DISEASE	0.000545554	0.020467085824608922
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608922
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.020467085824608922
3MC SYNDROME 2	0.000545554	0.020467085824608922
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.020467085824608922
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.020467085824608922
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.020467085824608922
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.020467085824608922
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.020467085824608922
WOLMAN DISEASE	0.000545554	0.020467085824608922
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.020467085824608922
CHAR SYNDROME	0.000545554	0.020467085824608922
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.020467085824608922
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.020467085824608922
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.020467085824608922
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.020467085824608922
BRESEK SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.020467085824608922
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.020467085824608922
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.020467085824608922
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
FRIED SYNDROME	0.000545554	0.020467085824608922
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.020467085824608922
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.020467085824608922
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.020467085824608922
TREACHER-COLLINS SYNDROME	0.000545554	0.020467085824608922
SEPTOOPTIC DYSPLASIA	0.000545554	0.020467085824608922
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.020467085824608922
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.020467085824608922
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.020467085824608922
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.000545554	0.020467085824608922
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.020467085824608922
CRANIOFRONTONASAL SYNDROME; CFNS	0.000545554	0.020467085824608922
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.000545554	0.020467085824608922
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
CURRARINO SYNDROME	0.000545554	0.020467085824608922
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.020467085824608922
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.020467085824608922
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.020467085824608922
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.020467085824608922
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.020467085824608922
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.020467085824608922
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.020467085824608922
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020467085824608922
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.020467085824608922
HYDROXYKYNURENINURIA	0.000545554	0.020467085824608922
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.020467085824608922
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.020467085824608922
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000545554	0.020467085824608922
ALG6-CDG	0.000545554	0.020467085824608922
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.020467085824608922
AUSTRALIA ANTIGEN	0.000545554	0.020467085824608922
SYNDROMIC DIARRHEA	0.000545554	0.020467085824608922
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.020467085824608922
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.020467085824608922
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.020467085824608922
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.020467085824608922
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.020467085824608922
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.020467085824608922
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.020467085824608922
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.020467085824608922
NOONAN SYNDROME 11; NS11	0.000545554	0.020467085824608922
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.020467085824608922
STEEL SYNDROME; STLS	0.000545554	0.020467085824608922
TRISOMY 17P	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.020467085824608922
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
SECKEL SYNDROME 9; SCKL9	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.020467085824608922
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.020467085824608922
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.020467085824608922
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.020467085824608922
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.020467085824608922
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.020467085824608922
PENTASOMY X	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.020467085824608922
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
N SYNDROME	0.000545554	0.020467085824608922
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.020467085824608922
ALAZAMI SYNDROME; ALAZS	0.000545554	0.020467085824608922
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.020467085824608922
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.020467085824608922
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.020467085824608922
TRANSALDOLASE DEFICIENCY	0.000545554	0.020467085824608922
ZECHI-CEIDE SYNDROME	0.000545554	0.020467085824608922
JOUBERT SYNDROME 26	0.000545554	0.020467085824608922
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.020467085824608922
JOUBERT SYNDROME 24	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.020467085824608922
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.020467085824608922
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.020467085824608922
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.020467085824608922
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.020467085824608922
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
OGDEN SYNDROME	0.000545554	0.020467085824608922
GERODERMA OSTEODYSPLASTICA	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.020467085824608922
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.020467085824608922
GERMAN SYNDROME	0.000545554	0.020467085824608922
DEXTROCARDIA	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.020467085824608922
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.020467085824608922
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.020467085824608922
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020467085824608922
FRIAS SYNDROME	0.000545554	0.020467085824608922
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.020467085824608922
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.020467085824608922
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.020467085824608922
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.020467085824608922
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.020467085824608922
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.020467085824608922
MEVALONIC ACIDURIA; MEVA	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.020467085824608922
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.020467085824608922
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.020467085824608922
EVEN-PLUS SYNDROME	0.000545554	0.020467085824608922
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.020467085824608922
OKAMOTO SYNDROME	0.000545554	0.020467085824608922
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.020467085824608922
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.020467085824608922
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.020467085824608922
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.020467085824608922
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.020467085824608922
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.020467085824608922
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.020467085824608922
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.020467085824608922
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.020467085824608922
CHOPS SYNDROME; CHOPS	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.020467085824608922
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.020467085824608922
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020467085824608922
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.020467085824608922
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.020467085824608922
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.020467085824608922
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.020467085824608922
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.020467085824608922
AL-RAQAD SYNDROME; ARS	0.000545554	0.020467085824608922
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.020467085824608922
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.020467085824608922
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.020467085824608922
MICROVILLUS INCLUSION DISEASE	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.020467085824608922
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.020467085824608922
HOLOPROSENCEPHALY 11	0.000545554	0.020467085824608922
CINCA SYNDROME	0.000545554	0.020467085824608922
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.020467085824608922
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.020467085824608922
RING CHROMOSOME 12 SYNDROME	0.000545554	0.020467085824608922
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.020467085824608922
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.020467085824608922
TRISOMY 9P	0.000545554	0.020467085824608922
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020467085824608922
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.020467085824608922
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.020467085824608922
ROIFMAN SYNDROME; RFMN	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.020467085824608922
HYPERTRICHOSIS CUBITI	0.000545554	0.020467085824608922
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.020467085824608922
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.020467085824608922
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.020467085824608922
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.020467085824608922
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.020467085824608922
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.020467085824608922
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.020467085824608922
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.000545554	0.020467085824608922
MIETENS SYNDROME	0.000545554	0.020467085824608922
SENIOR-LOKEN SYNDROME 9	0.000545554	0.020467085824608922
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.020467085824608922
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.020467085824608922
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.020467085824608922
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.020467085824608922
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.020467085824608922
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.020467085824608922
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.020467085824608922
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.020467085824608922
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.020467085824608922
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.020467085824608922
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.020467085824608922
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.020467085824608922
NOONAN SYNDROME 9; NS9	0.000545554	0.020467085824608922
OTOFACIOCERVICAL SYNDROME	0.000545554	0.020467085824608922
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.020467085824608922
LIG4 SYNDROME	0.000545554	0.020467085824608922
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.020467085824608922
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.020467085824608922
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.020467085824608922
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.020467085824608922
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.020467085824608922
HEREDITARY OROTIC ACIDURIA	0.000545554	0.020467085824608922
HURLER SYNDROME	0.000545554	0.020467085824608922
TEMTAMY SYNDROME	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.020467085824608922
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.020467085824608922
17P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.020467085824608922
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.020467085824608922
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.020467085824608922
1P21.3 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.020467085824608922
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.020467085824608922
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.020467085824608922
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.020467085824608922
CONGENITAL VARICELLA SYNDROME	0.000545554	0.020467085824608922
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.020467085824608922
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.020467085824608922
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.020467085824608922
ROBERTS SYNDROME	0.000545554	0.020467085824608922
DISTAL TRISOMY 6P	0.000545554	0.020467085824608922
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.020467085824608922
NOONAN SYNDROME 2; NS2	0.000545554	0.020467085824608922
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.020467085824608922
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.020467085824608922
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.020467085824608922
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.020467085824608922
TRISOMY 8Q	0.000545554	0.020467085824608922
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.020467085824608922
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.020467085824608922
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.020467085824608922
RAHMAN SYNDROME	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA	0.000545554	0.020467085824608922
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.020467085824608922
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.020467085824608922
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.020467085824608922
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.020467085824608922
SAY-BARBER-MILLER SYNDROME	0.000545554	0.020467085824608922
GENITOPATELLAR SYNDROME; GTPTS	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.020467085824608922
DISTAL TRISOMY 18Q	0.000545554	0.020467085824608922
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.020467085824608922
OCCIPITAL HORN SYNDROME	0.000545554	0.020467085824608922
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.020467085824608922
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.020467085824608922
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.020467085824608922
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.020467085824608922
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.020467085824608922
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.020467085824608922
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.020467085824608922
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.020467085824608922
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.020467085824608922
ALAZAMI-YUAN SYNDROME	0.000545554	0.020467085824608922
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.020467085824608922
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020467085824608922
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.020467085824608922
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020467085824608922
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020467085824608922
XIA-GIBBS SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.020467085824608922
COLE-CARPENTER SYNDROME	0.000545554	0.020467085824608922
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.020467085824608922
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.020467085824608922
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.020467085824608922
SECKEL SYNDROME 8; SCKL8	0.000545554	0.020467085824608922
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.020467085824608922
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020467085824608922
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.020467085824608922
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.020467085824608922
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.020467085824608922
OPTIC ATROPHY 11; OPA11	0.000545554	0.020467085824608922
CDAGS SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.020467085824608922
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.020467085824608922
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.020467085824608922
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.000545554	0.020467085824608922
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.020467085824608922
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.020467085824608922
CULLER-JONES SYNDROME; CJS	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.020467085824608922
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
MEIER-GORLIN SYNDROME 7	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 2	0.000545554	0.020467085824608922
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.020467085824608922
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.020467085824608922
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020311956543392476
PRADER-WILLI SYNDROME	0.000541419	0.020311956543392476
SCLERODERMA	0.000541419	0.020311956543392476
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.020311956543392476
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392476
RABIES	0.000541419	0.020311956543392476
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392476
CRYPTOCOCCOSIS	0.000541419	0.020311956543392476
47,XYY SYNDROME	0.000541419	0.020311956543392476
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020311956543392476
ISOLATED SPINA BIFIDA	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.020311956543392476
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020311956543392476
SNEDDON SYNDROME	0.000541419	0.020311956543392476
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392476
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020311956543392476
COFS SYNDROME	0.000541419	0.020311956543392476
FOUNTAIN SYNDROME	0.000541419	0.020311956543392476
SJÃ–GREN-LARSSON SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020311956543392476
SCRUB TYPHUS	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020311956543392476
PROTEUS SYNDROME	0.000541419	0.020311956543392476
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.020311956543392476
MOGS-CDG	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000541419	0.020311956543392476
DISTAL MONOSOMY 7Q36	0.000541419	0.020311956543392476
ALG2-CDG	0.000541419	0.020311956543392476
MPDU1-CDG	0.000541419	0.020311956543392476
DPM1-CDG	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.020311956543392476
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392476
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.020311956543392476
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.000541419	0.020311956543392476
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.020311956543392476
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020311956543392476
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020311956543392476
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392476
COHEN SYNDROME	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020311956543392476
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.020311956543392476
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
ALG9-CDG	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392476
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020311956543392476
DISTAL TRISOMY 15Q	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020311956543392476
AUTISM	0.000541419	0.020311956543392476
DYSOSTEOSCLEROSIS	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392476
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020311956543392476
SECKEL SYNDROME 1; SCKL1	0.000541419	0.020311956543392476
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020311956543392476
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020311956543392476
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.000541419	0.020311956543392476
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020311956543392476
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020311956543392476
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020311956543392476
ROSAÃ-DORFMAN DISEASE	0.000541419	0.020311956543392476
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.020311956543392476
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.020311956543392476
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392476
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.020311956543392476
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392476
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392476
CROME SYNDROME	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392476
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.020311956543392476
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392476
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020311956543392476
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392476
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392476
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.020311956543392476
EPILEPSY, READING	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392476
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020311956543392476
PSEUDO-TORCH SYNDROME 2	0.000541419	0.020311956543392476
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.020311956543392476
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.020311956543392476
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.020311956543392476
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000541419	0.020311956543392476
HUNTINGTON DISEASE; HD	0.000541419	0.020311956543392476
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392476
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.020311956543392476
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.020311956543392476
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020311956543392476
PARTINGTON SYNDROME	0.000541419	0.020311956543392476
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020311956543392476
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392476
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020311956543392476
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392476
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020311956543392476
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392476
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.020311956543392476
INSULINOMA	0.000541419	0.020311956543392476
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392476
CROUZON SYNDROME	0.000541419	0.020311956543392476
NIPAH VIRUS DISEASE	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.020311956543392476
HADDAD SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020311956543392476
LASSA FEVER	0.000541419	0.020311956543392476
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020311956543392476
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.020311956543392476
SECONDARY SYRINGOMYELIA	0.000541419	0.020311956543392476
2Q33.1 DELETION SYNDROME	0.000541419	0.020311956543392476
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020311956543392476
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020311956543392476
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392476
DERMOTRICHIC SYNDROME	0.000541419	0.020311956543392476
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392476
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME	0.000541419	0.020311956543392476
ADRENOMYODYSTROPHY	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000541419	0.020311956543392476
CORNELIA DE LANGE SYNDROME 1	0.000541419	0.020311956543392476
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.020311956543392476
PAPILLORENAL SYNDROME	0.000541419	0.020311956543392476
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392476
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020311956543392476
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.020311956543392476
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.000541419	0.020311956543392476
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020311956543392476
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.020311956543392476
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392476
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020311956543392476
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.020311956543392476
ENCEPHALITIS LETHARGICA	0.000541419	0.020311956543392476
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.020311956543392476
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392476
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020311956543392476
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392476
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.020311956543392476
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.020311956543392476
BOWEN-CONRADI SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.020311956543392476
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.020311956543392476
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.020311956543392476
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020311956543392476
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020311956543392476
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020311956543392476
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392476
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.000541419	0.020311956543392476
CADASIL	0.000541419	0.020311956543392476
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392476
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020311956543392476
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020311956543392476
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020311956543392476
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020311956543392476
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392476
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.000541419	0.020311956543392476
FETAL GAUCHER DISEASE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392476
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.020311956543392476
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392476
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
MEHMO SYNDROME	0.000541419	0.020311956543392476
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.020311956543392476
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392476
SNEDDON SYNDROME	0.000541419	0.020311956543392476
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020311956543392476
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020311956543392476
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020311956543392476
FRAGILE X SYNDROME	0.000541419	0.020311956543392476
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.020311956543392476
PARIETAL FORAMINA	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.020311956543392476
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.020311956543392476
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.020311956543392476
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.020311956543392476
BETA-MANNOSIDOSIS	0.000541419	0.020311956543392476
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392476
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
ASPARTYLGLUCOSAMINURIA	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020311956543392476
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.020311956543392476
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392476
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020311956543392476
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392476
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392476
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.020311956543392476
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.020311956543392476
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.020311956543392476
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000541419	0.020311956543392476
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392476
GRANULOMATOSIS WITH POLYANGIITIS	0.000541419	0.020311956543392476
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020311956543392476
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020311956543392476
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392476
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020311956543392476
SYSTEMIC SCLEROSIS	0.000541419	0.020311956543392476
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.020311956543392476
ROMANO-WARD SYNDROME	0.000541419	0.020311956543392476
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392476
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020311956543392476
FRYNS SYNDROME; FRNS	0.000541419	0.020311956543392476
CLASSIC HOMOCYSTINURIA	0.000541419	0.020311956543392476
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392476
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 47	0.000541419	0.020311956543392476
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.020311956543392476
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392476
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392476
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392476
GLUTAMINE DEFICIENCY, CONGENITAL	0.000541419	0.020311956543392476
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020311956543392476
KLEEFSTRA SYNDROME	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392476
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020311956543392476
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392476
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.020311956543392476
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020311956543392476
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392476
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392476
INCONTINENTIA PIGMENTI; IP	0.000541419	0.020311956543392476
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
HHHH SYNDROME	0.000541419	0.020311956543392476
XP22.13P22.2 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020311956543392476
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.020311956543392476
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.020311956543392476
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.020311956543392476
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.020311956543392476
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.020311956543392476
FABRY DISEASE	0.000541419	0.020311956543392476
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.020311956543392476
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.020311956543392476
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392476
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392476
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020311956543392476
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392476
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.020311956543392476
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.020311956543392476
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA	0.000541419	0.020311956543392476
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
LISSENCEPHALY, X-LINKED, 2	0.000541419	0.020311956543392476
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392476
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.020311956543392476
MALAN OVERGROWTH SYNDROME	0.000541419	0.020311956543392476
COG5-CDG	0.000541419	0.020311956543392476
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020311956543392476
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020311956543392476
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392476
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020311956543392476
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392476
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392476
21Q22.11Q22.12 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.020311956543392476
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020311956543392476
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392476
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.020311956543392476
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS 2	0.000541419	0.020311956543392476
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.020311956543392476
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.020311956543392476
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020311956543392476
20P13 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
TAKAYASU ARTERITIS	0.000541419	0.020311956543392476
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020311956543392476
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.020311956543392476
NOCARDIOSIS	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020311956543392476
GURRIERI SYNDROME	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392476
MERCURY POISONING	0.000541419	0.020311956543392476
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392476
ATYPICAL RETT SYNDROME	0.000541419	0.020311956543392476
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.020311956543392476
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000541419	0.020311956543392476
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392476
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020311956543392476
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392476
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.020311956543392476
RIFT VALLEY FEVER	0.000541419	0.020311956543392476
EBOLA HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
LUJO HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392476
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020311956543392476
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.000541419	0.020311956543392476
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020311956543392476
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.020311956543392476
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392476
15Q OVERGROWTH SYNDROME	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.020311956543392476
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020311956543392476
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392476
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020311956543392476
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.020311956543392476
GALACTOSIALIDOSIS	0.000541419	0.020311956543392476
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.020311956543392476
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392476
CRONKHITE-CANADA SYNDROME	0.000541419	0.020311956543392476
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392476
CONGENITAL RUBELLA SYNDROME	0.000541419	0.020311956543392476
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.020311956543392476
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.020311956543392476
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.020311956543392476
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020311956543392476
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
GAUCHER DISEASE, PERINATAL LETHAL	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020311956543392476
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392476
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020311956543392476
GLIOBLASTOMA	0.000541419	0.020311956543392476
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020311956543392476
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020311956543392476
PORENCEPHALY	0.000541419	0.020311956543392476
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020311956543392476
ISOLATED BILIARY ATRESIA	0.000541419	0.020311956543392476
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392476
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.020311956543392476
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.020311956543392476
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392476
TRISOMY 13	0.000541419	0.020311956543392476
VIRAL HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020311956543392476
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.020311956543392476
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000541419	0.020311956543392476
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.000541419	0.020311956543392476
WORSTER-DROUGHT SYNDROME	0.000541419	0.020311956543392476
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.020311956543392476
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.020311956543392476
PROLACTINOMA	0.000541419	0.020311956543392476
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392476
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392476
LISSENCEPHALY 5; LIS5	0.000541419	0.020311956543392476
MENKES DISEASE	0.000541419	0.020311956543392476
HARROD SYNDROME	0.000541419	0.020311956543392476
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.020311956543392476
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020311956543392476
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020311956543392476
KRABBE DISEASE	0.000541419	0.020311956543392476
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.020311956543392476
HENNEKAM-BEEMER SYNDROME	0.000541419	0.020311956543392476
MYASTHENIA GRAVIS	0.000541419	0.020311956543392476
KEUTEL SYNDROME; KTLS	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392476
CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392476
CYSTATHIONINURIA	0.000541419	0.020311956543392476
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392476
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.020311956543392476
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.020311956543392476
WHIM SYNDROME	0.000541419	0.020311956543392476
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.000541419	0.020311956543392476
PITT-HOPKINS-LIKE SYNDROME	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.020311956543392476
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392476
CONGENITAL HYDROCEPHALUS	0.000541419	0.020311956543392476
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392476
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392476
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS	0.000541419	0.020311956543392476
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
COWDEN SYNDROME 5; CWS5	0.000541419	0.020311956543392476
COWDEN SYNDROME 6; CWS6	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392476
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.020311956543392476
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020311956543392476
FRYNS SYNDROME	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.020311956543392476
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020311956543392476
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392476
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.020311956543392476
HYPER-BETA-ALANINEMIA	0.000541419	0.020311956543392476
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.020311956543392476
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392476
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392476
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392476
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392476
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.020311956543392476
FAMILIAL THROMBOCYTOSIS	0.000541419	0.020311956543392476
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392476
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.020311956543392476
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.020311956543392476
BERNARD-SOULIER SYNDROME	0.000541419	0.020311956543392476
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020311956543392476
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392476
HYPERLYSINEMIA, TYPE I	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020311956543392476
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020311956543392476
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392476
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020311956543392476
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392476
ACROCARDIOFACIAL SYNDROME	0.000541419	0.020311956543392476
NORRIE DISEASE	0.000541419	0.020311956543392476
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392476
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020311956543392476
CORNELIA DE LANGE SYNDROME	0.000541419	0.020311956543392476
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392476
ONDINE SYNDROME	0.000541419	0.020311956543392476
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.020311956543392476
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392476
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.020311956543392476
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020311956543392476
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020311956543392476
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
THREONINEMIA	0.000541419	0.020311956543392476
TAY-SACHS DISEASE; TSD	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020311956543392476
FILIPPI SYNDROME; FLPIS	0.000541419	0.020311956543392476
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.020311956543392476
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.020311956543392476
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.020311956543392476
AICA-RIBOSIDURIA	0.000541419	0.020311956543392476
EPENDYMOMA	0.000541419	0.020311956543392476
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392476
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020311956543392476
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.020311956543392476
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.020311956543392476
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.020311956543392476
JUVENILE HUNTINGTON DISEASE	0.000541419	0.020311956543392476
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392476
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.020311956543392476
SUBEPENDYMOMA	0.000541419	0.020311956543392476
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020311956543392476
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.020311956543392476
ADRENOLEUKODYSTROPHY	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392476
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020311956543392476
MOYNAHAN SYNDROME	0.000541419	0.020311956543392476
MOYAMOYA DISEASE	0.000541419	0.020311956543392476
EPISODIC ATAXIA, TYPE 6	0.000541419	0.020311956543392476
MICROSPORIDIOSIS	0.000541419	0.020311956543392476
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.020311956543392476
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392476
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020311956543392476
PINEOBLASTOMA	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.020311956543392476
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392476
SLC39A8-CDG	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020311956543392476
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.020311956543392476
NEURAMINIDASE DEFICIENCY	0.000541419	0.020311956543392476
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020311956543392476
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.020311956543392476
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.020311956543392476
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.020311956543392476
SECKEL SYNDROME 7; SCKL7	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.020311956543392476
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392476
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
NOONAN SYNDROME 7; NS7	0.000541419	0.020311956543392476
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392476
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020311956543392476
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
LOWRY-MACLEAN SYNDROME	0.000541419	0.020311956543392476
4Q21 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392476
PHENYLKETONURIA	0.000541419	0.020311956543392476
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.020311956543392476
PERRAULT SYNDROME 3	0.000541419	0.020311956543392476
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020311956543392476
SANJAD-SAKATI SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020311956543392476
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.020311956543392476
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020311956543392476
